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Preservation of primary teeth, which has been affected by carious lesion or 
trauma, forms a major problem in pediatric dental practice. The principle of pulp 
treatment in primary dentition is that tooth should remain in mouth in a non-
pathological healthy condition to fulfill its role in primary dentition. Maintenance 
of primary tooth is important for development of arch form, esthetics, function, 
and mastication and also for normal emergence of permanent teeth. 
 
There are numerous pulpal procedures indicated in primary tooth. Pulpotomy is 
indicated when caries removal results in pulp exposure of primary tooth with 
normal or reversible pulpitis or after traumatic pulp exposure. The coronal pulp 
tissue is amputated and remaining radicular pulp tissue is judged to be vital by 
clinical and /or radiographic criteria. The objective is that radicular pulp should 
remain healthy without adverse clinical signs or symptoms such as sensitivity, 
pain or swelling. There should be no postoperative radiographic evidence of 
pathologic external or internal root resorption and no harm to succedaneous teeth. 
(AAPD 2004) 
 
Pulpotomy in primary dentition is developed along three lines-Devitalization, 
Preservation and Regeneration. Devitalization, - destroy the vital tissue example: 
Formocresol, electrosurgery. Preservation- maximal vital tissue is kept with no 
induction of reparative dentine-example glutaraldehyde. Regeneration, 
stimulation of dentine bridge – example Mineral Tri oxide Aggregate (MTA), 
Bone Morphogenic protein (BMP), osteogenic protein. 
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For decades formocresol has been widely used as pulpotomy medicament. It is 
used as standard for comparison of other materials. Yet there have been many 
concerns about the usage of formocresol like reports of positional alteration, 
enamel defects of sucedaneous tooth 30 (Rolling and Poulsen 1978), premature 
exfoliation of pulpotomized tooth when compared to its antimere24. In June 2004 
International agency of cancer IARC of WHO has stated that formaldehyde 
causes nasopharyngeal cancer, limited evidence that it causes nasal and para nasal 
sinus carcinoma and strong but not sufficient evidence that formaldehyde causes 
leukemia in humans. 
 
Criticism of formocresol has encouraged the search for newer alternatives. MTA 
introduced by Torabinejaad in 1993 has been useful in variety of clinical 
situations such as pulp capping, pulpotomy, and root end closures 43.  Its main 
components are tricalcium silicate, tricalcium aluminate, tricalcium oxide and 
silicon di -oxide. Bismuth is added to get radiopacity 7. It’s mechanism of action 
is similar to calcium hydroxide and induces osteogenic phenotype activities like 
alkaline phosphatase, osteonidogen, osteonectin, osteocalcin, osteopontin 5 and 
results in hard tissue bridge formation. 
 
It is currently available as two brand names, MTA Pro root (Densply) and MTA 
Angelus. The brands do not interfere with cytokine response by the macrophages 
39. Some of the previous studies have found better result when compared with 
other medicaments 2, 12, 14, 32, 6. It is available as grey and white types. Between the 
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two types of MTA grey appears to have better marginal adaptation and seal ability 
when compared with white MTA (Myriam, Bidar 2007).  
 
Thus this study has been undertaken to evaluate and compare the MTA and 
Formocresol as a pulpotomy medicament. 
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Aims and Objectives 
 
 
o To evaluate and compare MTA and Formocresol as a pulpotomy 
medicament by clinical and radiographic assessment. 
 
o To assess the histological features of MTA and Formocresol as pulpotomy 
medicaments. 
 
 16
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Review of Literature 
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A.M.Lauterstein, S.Pruzansky et al 196224 studied the effect of deciduous 
mandibular molar pulpotomy on the eruption of succedaneous premolar. 28 
children requiring pulpotomy on mandibular molars were included in the study. 
They were observed for a period of 4 years. Measurements pertaining to 
eruption of premolar teeth were obtained from oblique roentgenograms. It was 
seen when compared with eruption status of normal antimere, the succedaneous 
premolar beneath the pulpotomized teeth demonstrated significantly accelerated 
tendency to erupt. 
 
Robert H. Spedding, David F. Mitchell et al 196544 evaluated the effects of 
Formocresol and calcium hydroxide therapy on both primary and permanent 
teeth. The sample consisted of 36 primary and 12 young first permanent molars in 
3 monkeys approximately 20 months old.  21 teeth were treated with formocresol, 
and 15 of these were observed to be "fixed" to an apical half or third depth. 20 
contained vital tissue in the apical third, half, or greater portion of the canals. One 
tooth was not available for study and was considered a failure. Dentin chips 
obstructing the canals of 5 teeth apparently prevented pulpal fixation. 3 pulps 
treated with formocresol revealed fixed pyknotic leucocytes dispersed among an 
excess of dentin chips blocking the root-canal entrances, and 2 pulps were 
observed to have leucocytes in the apical area. One of these 2 pulps was necrotic 
in the remaining portion of the canal, and the other pulp revealed peculiar 
syncytium in the apical third of the canal in which scattered inflammatory cells 
were observed. Successful treatment was at a 70 % level.  15 of 25 teeth treated 
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with Calcium hydroxide presented normal non-inflamed tissue. 10 teeth had 
inflamed or necrotic pulp tissues and the range of inflammation were judged to be 
from mild to severe. 60 % of the 25 teeth were successfully treated. No apparent 
differences were noted when comparing the effects of the pulp-dressing materials 
on the primary and the permanent teeth, with the exception of osteodentin, which 
was observed in the primary teeth treated with both pulp-dressing materials. The 
results of this study gave the impression that the formocresol pulp therapy is 
superior to the calcium hydroxide pulp therapy- for primary teeth. 
 
Louise B. Messer, Jay T. Cline 198030 evaluated the long-term effects of 
primary molar pulpotomies on succedaneous bicuspids. A total of 63 primary 
molar pulpotomy was done on teeth in children aged 5-11 years. Preoperative 
clinical and intra oral radiographs showing the periapical and interradicular areas 
of test molars and also the position and extent of development of all the bicuspids 
were recorded. The contra-lateral, adjacent and opposing bicuspids, not preceded 
by test molars, were designated control bicuspids (total 205) distributed as 
follows: maxillary first - 58; maxillary second - 56; mandibular first - 49; 
mandibular second - 42. In the control group, there were four congenitally 
missing bicuspids. Forty-three bicuspids which replaced successfully Buckley’s 
formocresol pulpotomized vital or non-vital primary molars, and twenty 
bicuspids, which erupted following unsuccessful pulpotomies requiring extraction 
of the preceding teeth, were examined for defects of position and enamel. In 
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comparison with contra lateral control tooth, test teeth in both the groups showed 
increased prevalence of rotation and enamel defects. 
 
Edna L.Pashley, Myers 198034-studied fate of the 14C-formaldehyde, which was 
absorbed following its application to pulpotomy sites. Tissue binding accounted 
for most of the systemic absorption. Tissue binding was highest in the liver and 
lowest in skeletal muscle. The high amount of 14C-activity in bile correlated with 
the high liver tissue/plasma values and demonstrated formaldehyde concentration 
by the biliary system. Formocresol was absorbed and distributed rapidly and 
widely throughout the body within minutes of being placed on a pulpotomy site. 
 
D.M. Ranly, Horn et al 198536 compared the antigenicity of the 
reaction products of protein with formaldehyde, glutaraldehyde, or 
dimethylsuberimidate (DMS). Rabbits were injected with rabbit 
serum albumin (RSA) which had been treated with one of the 
following solutions: phosphate-buffered saline, 2% glutaraldehyde, 
4% formaldehyde, or 2% DMS. The antisera from the rabbits were 
analyzed for elicited antibodies by the enzyme-linked 
immunosorbent assay (ELISA) and in a horseradish peroxidase 
(HRP) assay using a spot technique on nitrocellulose paper. The 
assays demonstrated that DMS-treated RSA was the most 
antigenic of the reaction products tested. The least provocative was 
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the glutaraldehyde-treated RSA; the reaction product of 
formaldehyde was intermediate. 
 
 
Inoue H, Muneyuki H et al 199720 studied nerve terminals 
formation during dentin bridge formation after pulpotomy in dog 
teeth using electron microscope. The relationship between pulpal 
nerves and the differentiation of pulpal cells into preodontoblast 
and odontoblast during the healing process after pulpotomy was 
studied. A total of 36 upper and lower teeth obtained from six 
adult dogs were used. The pulp chamber was opened with a sterile 
diamond bur, the coronal pulp was exposed, and the whole surface 
of the amputated pulp was capped with calcium hydroxide. The 
interval between pulpotomy and extraction was 5, 7, 10, 15, 20, 
30, 40, 50, and 60 days, and then specimens were examined ultra 
structurally. Close contact between fibroblast-like cells/osteoblast-
like cells and nerve terminals at the calcification front was 
observed in the early healing process after pulpotomy, suggesting a 
close relation between nerve fibers and pulpal cell differentiation. 
Waterhouse PJ, Nunn JH et al 200049- Evaluated the efficacy of calcium 
hydroxide and Formocresol pulpotomy by comparing clinical, radiographic and 
histological outcomes. 52 child patients were sequentially enrolled in the 
longitudinal clinical investigation, 26 boys and 26 girls. Primary molar teeth 
requiring vital pulp therapy were randomly allocated to either the formocresol 
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group (F) or the calcium hydroxide group (C). Coronal pulp amputation was 
prescribed only in teeth with vital, cariously exposed pulp tissue. 74 teeth were 
included in group F and 35 in group C. 5% (n = 2) of teeth in group F and 11 % of 
teeth (n = 4) in group C were terminated from the trial due to clinical and/or 
radiographic failure. Of the 6 teeth extracted, 5 were sufficiently intact to be 
retained for histological evaluation. Post-extraction radiographs were taken before 
specimen preparation, showed reactionary dentine barrier (bridge) formation in 
teeth treated with calcium hydroxide. Narrowing of root canals, indicative of 
appositional reactionary dentine deposition, was seen in both groups (F and C). 
Histological examination revealed that pus cells were evident in all specimens 
examined. There was also histological evidence of resorption of reactionary 
dentine within the root canal and that forming the calcified barrier (dentine 
bridge).  
P. J. Waterhouse, J H Nunn et al 200048 compared the clinical and radiological 
outcomes of Formocresol and calcium hydroxide pulpotomy. Forty-six carious 
primary molars were included in-group F (formocresol). The teeth were treated by 
coronal pulp amputation followed by a five-minute application of a 20% 
Buckley’s Formocresol solution to radicular pulp stumps. Thirty-eight carious 
primary molars were included in-group calcium hydroxide. Fifty-two patients 
were involved in the investigation (26 female and 26 male). Forty-six teeth were 
treated with formocresol and 38 teeth with calcium hydroxide. However, 5 treated 
teeth from 3 patients were lost to follow-up, leaving 44 in group F and 35 in 
group C. Eighty four percent (37/44) of teeth treated with formocresol and 77 
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percent (27/35) treated with calcium hydroxide were classified as clinically and 
radiographically successful, after a mean clinical review of 22.5 months (range 
6.1–38.5 months) and a mean radiographic review of 18.9 months (range .3–36.9 
months). This investigation confirmed the clinical efficacy of a one-fifth dilution 
of Buckley’s Formocresol as an agent in pulp treatment of cariously exposed, 
vital primary molar teeth.  
Holland, Valdir de Souza, Sueli Satomi Murata in 200116- studied the healing 
process of dog dental pulp after pulpotomy and pulp covering with MTA or 
Portland cement (PC). After pulpotomy, the pulp stumps of 26 roots of dog teeth 
were protected with MTA or PC. Sixty days after treatment, the animal was 
sacrificed and the specimens removed and prepared for histo - morphological 
analysis. There was a complete tubular hard tissue bridge in almost all specimens. 
In conclusion, MTA and PC show similar comparative results when used in direct 
pulp protection after pulpotomy. 
Holland, Valdir de Souza, Mauro Juvenal Nery in 2001 17 performed a study to 
observe the rat subcutaneous connective tissue reaction to implanted dentin tubes 
filled with mineral trioxide aggregate, Portland cement (PC) and calcium 
hydroxide (CH). The animals were sacrificed after 7 or 30 days and the 
decalcified specimens were prepared for histological analysis with polarized light 
and Von Kossa technique for mineralized tissues. It was concluded that MTA and 
PC encouraged hard tissue deposition similar to CH.  
 23
Schmitt, D., J. Lee et 200143- reviewed on multi faceted usage of MTA. MTA's 
physical and biological properties and the clinical techniques of direct pulp 
capping, apexification, and repair using MTA where calcium hydroxide therapy 
failed were discussed. 
 
 
Strange DM, Seale NS et al 200146-performed a retrospective study on 196 
primary molars (follow up=6 to 103 months; mean=49 months) on patients who 
received formocresol pulpotomies with the application of formocresol in the zinc 
oxide-eugenol sub-base. Traditional assessment of radiographic success and 
failure had yielded a success rate of 79%. Alternative assessment excluding 
internal resorption as a failure had yielded 99% success rate. Most frequently 
observed pulpal responses were calcific metamorphosis and internal resorption. 
Overall clinical success was 99%. The overall success rate has indicated that the 
formocresol pulpotomy technique incorporating formocresol in the zinc oxide-
eugenol sub-base can be a treatment modality for primary molars requiring pulp 
therapy. 
 
 
Holan G, Fuks AB, Keltz N 200215- performed a retrospective study to compare 
the success rates of formocresol pulpotomy in primary molars restored with 
stainless steel crowns (SSC) to those restored with amalgam (AM). Pulpotomized 
primary molars restored with SSC or AM were evaluated and defined as a 
"failure" when one or more of the following signs were present: internal (IR) or 
external (ER) root resorption and periapical (PR) or inter-radicular (IRR) 
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radiolucency. Pulp canal obliteration was not regarded as failure. 341 molars were 
available for follow-up evaluations ranging from 6 to 103 months. 47 (14%) teeth 
were defined as "failure," with a rate of 13% (36/287) for teeth restored with SSC 
and 20% (11/54) for AM. This difference was not statistically significant (P>0.1).  
Failure rates of 2 surfaces AM were 23% (7/30), much higher than that of one 
surface AM (10%, 2/20). Most of the failed teeth presented more than one 
pathologic finding, with IR being the most frequently observed (36%), followed 
by ER (31%), IRR (22%) and PR (11%). Pulp canal obliteration was detected in 
80% of the teeth, with similar rates in both groups. Pulpotomized primary molars 
can be successfully restored with one surface amalgam if their natural exfoliation 
is expected within not more than two years. 
 
 
King SR, McWhorter et al 200223 – conducted a survey on the usage of 
Formocresol among the practicing pediatric dentist.  84% of the respondents use 
formocresol for their primary tooth pulpotomies. Of those, 69% use full strength, 
27% use diluted and 4% don't know. Sources of diluted formocresol for those 
who use the diluted form include: 34% who buy it that way, 58% who dilute it 
themselves and 8% who have the pharmacy dilute it. Thus majority of pediatric 
dentists who use formocresol for primary tooth pulpotomies use a full strength 
formulation. 
 
Andelin WE, Shabahang S et al 20034-Compared the efficacy of MTA & BMP-
7 as pulp capping material. The hard tissue formed early in experimental pulp 
exposures capped with mineral trioxide aggregate (MTA) or bone morphogenetic 
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protein (BMP)-7 using dentin sialoprotein (DSP) as a marker was tested. The 
pulps were capped with MTA alone as a pulp-capping agent and final restoration 
or with BMP-7 followed by restoration with MTA. The specimens were prepared 
and evaluated histologically and with immunohistochemistry using polyclonal 
antibodies raised against rat DSP. Pulps capped with MTA formed hard tissue that 
demonstrated significantly more immunostaining for DSP compared with BMP-7 
(p = 0.0031). MTA-capped pulps also showed significantly more complete bridge 
formation compared with BMP-7 (p = 0.0008). Pulps capped with BMP-7 
demonstrated a hard tissue that was bone-like in appearance and devoid of DSP 
staining. 
 
Dominguez Ms, WitherspoonDE et al 200310- Histologically assessed various 
vital pulp-therapy materials.  Pulp capping and pulpotomy procedures were 
performed on 15 mongrel dogs. Three materials were used: calcium hydroxide, 
acid-etched dentin bonding, and mineral trioxide aggregate. Histologically 
mineral trioxide aggregate was a considerably better material than calcium 
hydroxide or acid-etched dentin bonding in maintaining the integrity of the pulp 
 
Hunter ML 200318-presented a paper on a case of premature exfoliation of 
primary molars that may be related to the use of formocresol in a multivisit 
pulpotomy technique. 
 
Josette Camilleri, Franco E. Montesin  et al 20037 – carried out  a  study to 
determine the constitution of a commercially available root-end filling material, 
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mineral trioxide aggregate, (MTA) (ProRoot MTA, Tulsa Dental, Tulsa, OK, 
USA). Results showed that white MTA was composed primarily of calcium, 
silicon, bismuth and oxygen, while the gray MTA had small pecks of iron and 
aluminum. The XRD analysis showed gray MTA to be composed primarily of 
tricalcium silicate and dicalcium silicate. The surface morphology of the materials 
differed under the various conditions, particularly following immersion in 
phosphate solution with crystal formation. The commercial versions of MTA 
were shown to have broadly similar constitution to ordinary Portland cement 
except for the addition of bismuth compounds. The white MTA did not contain 
iron.  
 
Salko N, Joseph B, Juniad TA et al-200340 Compared bioactive glass, mineral 
trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat 
molar. Pulpotomies were performed in 80 maxillary first molars of Sprague 
Dawley rats, and pulp stumps were covered with BAG, FC, FS, and MTA. 
Histologic analysis was performed at 2 weeks and then at 4 weeks after treatment. 
At 2 weeks, MTA samples showed some acute inflammatory cells around the 
material with evidence of macrophages in the radicular pulp. Dentine bridge 
formation with normal pulp histology was a consistent finding at 2 and 4 weeks 
with MTA. Ferric sulfate showed moderate inflammation of pulp with widespread 
necrosis in coronal pulp at 2 and 4 weeks. Formocresol showed zones of atrophy, 
inflammation, and fibrosis. Fibrosis was more extensive at 4 weeks with evidence 
of calcification in certain samples. Among the materials tested, MTA performed 
ideally as a pulpotomy agent causing dentine bridge formation while 
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simultaneously maintaining normal pulpal histology. It appeared that BAG 
induced an inflammatory response at 2 weeks with resolution of inflammation at 4 
weeks. 
 
 
Zarzar PA, Rosenblatt, Costa Jr et al-200350- undertook a control study on 
mutagenicity of Buckley's original formulation. Lymphocyte cultures obtained 
from the peripheral blood of children aged from 5 to 10 years old was assessed. 
The sample comprised 20 children who had primary teeth with cariously exposed 
vital pulps. Two venous blood samples were collected (6-8 ml) from each child, 
the first prior to vital pulpotomy (control group) and the second 24 h after 
pulpotomy (treated group). The peripheral lymphocytes were grown in a complete 
culture medium consisting of 78% RPMI 1640 medium (a), supplemented with 
streptomycin (0.01 mg/ml), penicillin (0.005 ml (-1)), 20% fetal bovine serum (b) 
and 2% phytohemagglutinin (c). The cytogenetic analysis was blindly 
investigated. There was no statistically significant difference in clinical doses 
between the control and treated groups, for the chromosomal aberrations 
(P=0.251) and for the total chromosomal breaks (P=0.149). Although there were 
no statistically significant differences between the control and treated groups, 
Buckley's formocresol was mutagenic for one patient, raising doubt about the 
desirability of its use for pulpotomies in children. The results revealed that, from a 
statistical standpoint, formocresol was not mutagenic. However, further 
investigations are required, with a larger sample, in patients needing more than 
one pulpotomy in order to observe whether an increase in the quantity of the drug 
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would increase the quantity of chromosome aberrations and also to verify 
individual susceptibility to chromosome alterations with the usage of formocresol. 
 
 
 
Agamy HA, Bakry NS et al 20042-Evaluated the efficacy of gray MTA, white 
MTA and Formocresol as a pulpotomy agent in primary teeth. Twenty-four 
children, each with at least 3 primary molars requiring pulpotomy, were selected 
for study's clinical and radiographic portion. An additional 15 carious primary 
teeth planned for serial extractions were selected for this study's histologic 
portion. All selected teeth were evenly divided into 3 test groups and treated with 
pulpotomies. Gray MTA was used as the pulp dressing for one third of the teeth, 
white MTA was the dressing for one third, and the remaining one third were 
treated with formocresol. The treated teeth selected for the clinical and 
radiographic evaluations were monitored periodically for 12 months. The treated 
teeth selected for histologic study were monitored periodically and extracted 6 
months postoperatively. Four children with 12 pulpotomized teeth failed to return 
for any follow-up evaluations in the clinical and radiographic study. Of the 
remaining 60 teeth in 20 patients, 1 tooth (gray MTA) exfoliated normally and 6 
teeth (4 white MTA and 2 formocresol) failed due to abscesses. The remaining 53 
teeth appeared to be clinically and radiographically successful 12 months 
postoperatively. Pulp canal obliteration was a radiographic finding in 11 teeth 
treated with gray MTA and 1 tooth treated with white MTA. In the histologic 
study, both types of MTA successfully induced thick dentin bridge formation at 
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the amputation sites, while formocresol induced thin, poorly calcified dentin. 
Teeth treated with gray MTA demonstrated pulp architecture nearest to normal 
pulp by preserving the odontoblastic layer and delicate fibrocellular matrix, yet 
few inflammatory cells or isolated calcified bodies were seen. Teeth treated with 
white MTA showed a denser fibrotic pattern, with more isolated calcifications in 
the pulp tissue along with secondary dentin formation. It’s concluded that Gray 
MTA appears to be superior to white MTA and formocresol as a pulp dressing for 
pulpotomized primary teeth. 
 
S. Bonson, B.G. Jeansonne et al 20045- evaluated cytotoxicity of root end filling 
materials using gingival and periodontal fibroblasts. Many of the root-end filling 
materials examined were initially cytotoxic to both PDL and gingival fibroblasts 
in co-culture experiments; however, this was reduced after the materials were 
washed in either mineral trioxide aggregate (MTA) or hybrid ionomer composite 
resin (HICR) for 2 wks. PDL fibroblasts displayed enhanced proliferation on 
MTA and survival on amalgam when compared with gingival fibroblasts. MTA 
preferentially induced alkaline phosphatase expression and activity in both PDL 
and gingival fibroblasts. In contrast, HICR inhibited alkaline phosphatase 
expression and activity.  
 
In addition, MTA and HICR repressed pleiotrophin in PDL fibroblasts, while 
HICR repressed periostin in both fibroblasts. Analysis of their data indicates that 
MTA generally induces an osteogenic phenotype (alkaline phosphatase, 
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osteonidogen, osteonectin, and osteopontin), while HICR tended to inhibit the 
expression of osteogenic transcripts (alkaline phosphatase, periostin, pleiotrophin).  
 
S.E. Jabbarifar DD, A.A.Khademi DD 200421 - compared success rate of 
Formocresol Pulpotomy versus Mineral Trioxide Aggregate in primary 
molar. 64 primary molars of children aged 5-8 years old, were 
pulpotomized by Formocresol (FC) or Mineral trioxide aggregate (MTA). 
The selected teeth were evaluated by clinical assess and radiographic 
periapical X-ray examination to be suitable for pulpotomy. 64 teeth in MTA 
pulpotomy and FC pulpotomy groups were examined during follow up. 
Two of second primary molars in MTA group and three of them in FC 
group showed internal root resorption. After 6 and 12 months, 60 teeth 
with MTA pulpotomy and FC pulpotomy did not show any clinical or 
radiographic sign and symptom. Success rate in MTA group was 93.75 
percent and in FC group was 90.6 percent after one year. Average 
success and failure rates in two groups were 92.8 and 7.8 percent. 
Average differences between success and failure rates of two treatment 
methods were not significant.  Findings of this study show that mineral 
trioxide aggregate can be an alternative procedure for FC pulpotomy of 
primary tooth. 
 
Kalskar RR, Damle S.G 200422- compared the efficacy of lyophilized freeze-
dried platelet derived preparation with calcium hydroxide as pulpotomy agents in 
primary molars. Fifty-six primary molars in 28 children were treated by a 
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conventional pulpotomy technique. 28 teeth were treated by lyophilized freeze-
dried platelet derived preparation and another 28 by calcium hydroxide. Clinical 
evaluation was carried out at 1, 3, and 6-months interval and the radiographic 
evaluation was carried out at 1 and 6-months. The success rate of lyophilized 
freeze-dried platelet derived preparation proved better than calcium hydroxide.. 
 
Renato Menezes, Clóvis Monteiro Bramante et al 200427- studied the pulp 
response of dog’s teeth after pulpotomy and direct pulp protection with MTA 
Angelus and white Portland cement. Thirty-eight pulp remnants were protected 
with these materials. 120 days after treatment, the animals were sacrificed and the 
specimens removed and prepared for histological analysis. Both materials 
demonstrated the same results when used as pulp capping materials, inducing hard 
tissue bridge formation and maintaining pulp vitality in all specimens. The MTA 
Angelus and the white Portland cement showed to be effective as pulp protection 
materials following pulpotomy 
 
Menezes R, Bramante, et al 200429- investigated the pulpal response of dogs' 
teeth after pulpotomy and direct pulp protection with MTA Angelus, ProRoot, 
Portland cement and white Portland cement. Seventy-six teeth were treated with 
these materials. 120 days after treatment, the animals were sacrificed and the 
specimens prepared for histological analysis. All the materials demonstrated 
similar results when used as pulp-capping materials. Pulp vitality was maintained 
in all specimens and the pulp had healed with a hard tissue bridge. Thus the 
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materials used in the study were equally effective as pulp protection materials 
following pulpotomy. 
 
H. Razmi, M. Zarrabian et al200438- evaluated the tissue reaction to implanted 
MTA, Portland cement and Root MTA in the mandible of cats. Under asepsis 
condition and general anesthesia, a mucoperiosteal flap, following the application 
of local anesthesia, was elevated to expose mandibular symphysis. Two small 
holes in both sides of mandible were drilled. MTA, Portland cement and Root 
MTA were mixed according to the manufacturers, recommendation and placed in 
bony cavities. In positive control group, the test material was Zinc oxide powder 
plus tricresoformalin. In negative control group, the bony cavities were left 
untreated. After 3, 6 and 12 weeks, the animals were sacrificed and the 
mandibular sections were prepared for histologic examination under light 
microscope. The physical and histological results observed with MTA are similar 
to those of Root MTA and Portland cement. The authors suggest long- term 
studies with larger number of samples. 
 
M. Gallas Torreira, A.A.Dos Santos et al 200447- investigated bone response 
after implantation of MTA (Mineral Trioxide Aggregate) in the rabbit mandible. 
Experiments were carried out on the right mandibular body of 8 adult male 
rabbits. The animals were divided into two groups (control group and test group). 
In this in vivo study, MTA was used as an interpositional graft material in critical-
size bone defects of rabbit mandibles. The animals were sacrificed on day 30 after 
surgery. The samples obtained from the mandibles were subjected to histological 
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procedures, which permitted the collection of sections with a thickness of 
60±10µm. The sections were stained with Haematoxylin and Eosin and Goldner 
Trichrome stain and examined under a light microscope. No important 
inflammatory reactions were detected in any of the samples of the treated group. 
The results confirm the excellent biocompatibility of MTA. The implantation of 
MTA in bone defects led to bone regeneration 4 weeks after surgery. However, 
the growth rate was not significant and the amount of newly formed bone was 
limited with the use of MTA in this specific application. Sample examination did 
not suggest complete evidence of new bone growth from either an inductive or 
conductive perspective. 
 
Alexandra Mussolino de Queiroz; Sada Assed et al 20053- evaluated the 
biocompatibility of mineral trioxide aggregate (MTA) as a direct capping agent in 
dog’s teeth. Class I cavities were prepared in 26 teeth from 3 adult dogs. MTA 
was applied over the exposed pulp in 13 teeth and paste of calcium hydroxide plus 
distilled water (control) was applied in the remaining 13 teeth. After 90 days, the 
animals were killed; the maxilla and mandible dissected and sectioned to obtain 
individual roots. Histologically pulp and periapical response observed with the 
use of MTA was similar to that of calcium hydroxide paste. MTA presented 
excellent response when used for direct pulp capping. 
 
Casas, David J. Kenny 20058- the authors’ expresses at least 3 areas of concern 
with Formocresol usage: mutagenicity, carcinogenicity and immune sensitization. 
The formocresol pulpotomy, one-fifth dilution or full-strength, continues to be the 
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standard in many clinical trainings. Although many programs provide instruction 
of alternative techniques, less than a third offer clinical exposure to non aldehyde 
methods. The authors suggest alternatives to formocresol pulpotomy be used in 
future practice. 
 
Farsi. N, Alamoundi N, et al 200512 compared clinically and radiographically, 
the mineral trioxide aggregate to formocresol when used as medicaments in 
pulpotomized vital human primary molars. The sample consisted of 120 primary 
molars; all teeth were treated with the same conventional pulpotomy technique. 
Sixty molars received FC and 60 received MTA throughout a random selection 
technique. At the end of 24 month, 74 molars (36 FC, 38 MTA) available for 
clinical and radiographic evaluation. None of the MTA treated teeth showed any 
clinical or radiographic pathology, while the FC group showed a success rate of 
86.8% radiographically and 98.6% clinically. The difference between the two 
groups in the radiographic outcomes was statistically significant. It was concluded 
that MTA treated molars demonstrated significantly greater success. MTA seems 
to be a suitable replacement for formocresol in pulpotomized primary teeth.  
Guelmann M, Mc Ilwain MF etal 200513- retrospectively assessed the overall 
performance of formocresol pulpotomies in primary molars when definitively 
restored with a resin-based material; and compared the results to previously 
published studies using more traditional restorative techniques (stainless steel 
crown, amalgam). Radiographic success was determined by the absence of 
furcation/periapical osseous radiolucency and internal/external pathologic root 
 35
resorption. Patient’s age, gender, tooth type and arch, follow-up time, ZOE base 
type used (IRM only or IRM with glass ionomer overlay), and number of surfaces 
involved were the variables analyzed in the study. Overall, restoration of 
pulpotomized primary molars with resin-based material was inferior to reported 
success rates using stainless steel crowns. When proximal surfaces were restored, 
the failure rate (26%) was comparable to amalgam (23%). 
Holan G, Eidelman E, et al 200514- assessed the effect of mineral trioxide 
aggregate   and formocresol as pulp dressing material in primary molars.  MTA 
group 33 teeth, FC group 29 teeth were followed up clinically and 
radiographically between 4 and 74 months. The mean follow-up time was 38 
months. Twenty-nine teeth were followed until uneventful shedding (mean=33 
months). Failures were detected after a mean period of 16 months (range=4 to 
30). The success rate of pulpotomy was 97% for MTA (1 failure) and 83% for FC 
(5 failures). Eight teeth presented internal resorption. In 4 of them (2 of each 
group), progress of the resorption process stopped and the pulp tissue was 
replaced by a radiopaque calcified tissue. Pulp canal obliteration was observed in 
58% of the MTA group and in 52% of the FC group (total=55%). MTA showed a 
higher (though not statistically significant) long-term clinical and radiographic 
success rate than formocresol, and can be recommended as its replacement as, 
unlike FC, MTA does not induce undesirable responses.  
Huth KC, Paschos E et al 200519- compared the relative effectiveness of the Er: 
YAG laser, calcium hydroxide, and ferric sulfate techniques with that of dilute 
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formocresol as pulpotomy agent.  200 primary molars in 107 healthy children 
were included and randomly allocated to one of the techniques. The treated teeth 
were blindly re-evaluated after 6, 12, 18, and24 months. After 24 months, the 
following total and clinical success rates were determined (%): formocresol 85 
(96), laser 78 (93), calcium hydroxide 53 (87), and ferric sulfate 86 (100). Only 
calcium hydroxide performed significantly worse than formocresol (p = 0.001, 
odds ratio = 5.6, 95% confidence interval 2.0-15.5). In conclusion, calcium 
hydroxide is less appropriate for pulpotomies than formocresol. 
 
Maroto M, Barberia E et al 200526 - evaluated mineral trioxide aggregate as a 
pulpotomy medicament in primary teeth. Seven patients were selected and a total 
of 20 molars and two canines were treated with pulpotomy procedures using 
MTA. After 6 months, 55% of the molars and 100% of the canines treated showed 
radiographic signs of dentin bridge formation. Also, 6 months after treatment, 
60% of the molars showed root canal calcification (obliteration). Color change of 
the crown of the canines treated was noticeable. No clinical or radiographic signs 
of pathology were observed. 
Marcella Fridland, Rafel Rosado 200525- tested mineral trioxide aggregate 
solubility and porosity with different water-to-powder proportions. The study also 
determined the chemical composition of the salts by dissolving four sets of 
specimens using the following water-to-powder proportions were prepared: 0.26, 
0.28, 0.30, and 0.33 grams of water per gram of cement. The latter is the ratio 
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recommended by the manufacturer. It was determined that the degree of solubility 
and porosity increased as the water-to-powder ratio increased. Significant 
differences were found among the sets of specimens. The chemical analyses of 
the salts dissolved by in the water identified the presence of calcium as the main 
chemical compound. The pH level of the solution was highly alkaline, ranging 
between 11.94 and 11.99. It can be stated that the calcium found in the solution 
should be in its hydroxide state at this high pH level. This ability to release 
calcium hydroxide could be of clinical significance because it could be related to 
proven capacity to induce mineralization.  
 
JVN Menezes, Granjeiro et al 200528- studied in-vitro toxicity of primary teeth 
pulpotomy agents based on MTT cell proliferation test and Neutral Red uptake 
colorimetric essays. Buckley's formocresol (FC), 20% diluted formocresol (FCD), 
calcium hydroxide P.A. (HC), 15,5% ferric sulfate solution (SF) and mineral 
trioxide aggregate (MTA) was tested on Balb-c 3T3 mouse fibroblasts. The cells 
were seeded in 24-well culture plates at a density of 3.104 cells/well and 
incubated for 24 h. to allow attachment. Extracts from the substances were 
obtained according to ISO 10993-12 standards. After incubation at a 37oC 
temperature in air atmosphere of 5% of CO2, medium was aspirated and replaced 
with 1, 0 ml of the extracts. The plates were incubated for 24 h. and the 
cytotoxicity was assessed in a spectrophotometer. The absorbance was read at 560 
nm. There were two independent experiments in triplicates. Mean test absorptions 
were calculated and expressed as a percentage of the control cells together with 
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standard deviations. The results showed that the cytotoxicity can be ranked as: 
FC>FCD>SF>HC>MTA. Neutral Red test results showed that cells exposed to 
MTA, HC and SF did not affect the cells, when compared with control group, 
while FC and FCD reduced cell viability in approximately 65 %, when compared 
with control (p<0,05). The MTT assay demonstrated that the cytotoxicity of the 
materials can be ranked as: FC>FCD>SF>HC>MTA, with all the substances 
statistically significant different compared with control cells (p<0.01). Thus MTA 
was the less cytotoxic pulpotomy agent. 
 
 
 
Naik S, Hegde AM 200532- tested clinically MTA as a pulpotomy agent. 50 
primary molars in children whose pulpal status warranted pulpotomy were 
randomly assigned to either control (formocresol) or experimental (MTA) group 
of 25 teeth. Each. Following pulpotomy all the 50 teeth were restored with 
stainless steel crown after 24 hours.  Finally the patients were recalled after 1 
month, 3 months and 6 months respectively and evaluated clinically and 
radiographically. Of the 50 teeth selected, 3 were not available for further follow-
up after 1 month. The follow up after 1 month, 3 months and 6 months did not 
reveal any clinical or radiographic pathological findings in the rest of the 47 teeth. 
Hence, no statistical analysis was performed regarding the success of the 
treatment. The only significant findings were the discoloration of 60% of the teeth 
where MTA was used as a medicament after 24 hours, but which was later 
masked by restoring with a stainless steel crown 
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Rezende, T. M. B.; Vargas et al 200539 -tested the effect of two commercial 
brands of grey mineral trioxide aggregate (ProRoot® and MTA-Ângelus®) on 
cytokine production by M1  and M2 inflammatory macrophages. M1 and M2 
peritoneal inflammatory macrophages were obtained and cultured in vitro in the 
presence of MTA. The cellular viability and the production of tumour necrosis 
factor-α, interleukin (IL)-12 and IL-10 in response to stimulation with interferon-γ 
and Fusobacterium nucleatum or Peptostreptococcus anaerobius were evaluated. 
Results showed that cements did not interfere with cellular viability or with 
cytokine production by either type of macrophage. However, M2 macrophages 
produced higher levels of IL-10 when stimulated with F. nucleatum than M1 
macrophages (P<0.05). Thus brands of MTA evaluated did not interfere in the 
cytokine response by M1 or M2 macrophages to the two bacteria tested. However, 
a difference in cytokine production between the two types of macrophages was 
found. 
 
N.k Sarkar, R.Caicedo et al 200542- Studied  interactions of mineral trioxide 
aggregate with a synthetic tissue fluid using inductively coupled plasma—atomic 
emission spectroscopy, scanning electron microscopy, energy dispersive X-ray 
analysis, and X-ray diffraction. Mineral trioxide aggregate released its metallic 
constituents and produced precipitates with a composition and structure similar to 
that of hydroxyapatite [Ca10(PO4)6(OH)2–HA]. The authors conclude that Ca, 
the dominant ion released from mineral trioxide aggregate, reacts with phosphates 
in synthetic tissue fluid, yielding hydroxyapatite. The dentin—mineral trioxide 
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aggregate interfacial layer results from a similar reaction. The sealing ability, 
biocompatibility, and dentinogenic activity of mineral trioxide aggregate is 
attributed to these physicochemical reactions. 
 
Saltzmann B, Sigal M, Clokie C et al 200541- evaluated laser-MTA and 
Formocresol pulpotomy technique.  A total of 26 pairs of teeth from 16 patients 
were selected based on clinical and radiographic criteria with mean age=5.10 
years. One tooth from each pair was randomly assigned to either the laser-MTA 
pulpotomy group or the formocresol-ZOE pulpotomy group. All teeth were 
followed up clinically and radiographically at 2.3, 5.2, 9.5 and 15.7 months. The 
laser-MTA pulpotomy showed reduced radiographic success rates compared to 
the formocresol-ZOE pulpotomy at 15.7 months; however, these results were not 
statistically significant.  
 
R Caicedo, PV Abbott 20066- analyzed clinical, radiographic and histological 
effects of mineral trioxide aggregate as a direct pulp capping and pulpotomy agent 
of primary teeth. After pulp treatment teeth were reviewed after one month, two 
months, three months, four months, and five months and immediately before 
extraction, which was typically about six months following the operative 
procedure. At each review appointment, the presence or absence of the following 
was assessed clinically: pain; tenderness to percussion; gingival inflammation; 
exudate; draining sinus; mobility and pulp status. Radiographs were taken prior to 
treatment, after one month and prior to extraction – these were compared to assess 
whether any root resorption, widening of the periodontal ligament space, or 
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periapical and furcation radiolucencies had developed following treatment. 
Development of periodontal pockets and dentinal bridges were also noted. After 
the teeth were extracted, they were fixed in formalin, stained with H & E stain, 
and then examined under a light microscope.  Histologically, the presence of 
intrapulpal calcifications, dentinal bridges, odontoblasts, cementum formation, 
pulp tissue, inflammatory infiltrate and internal resorption were evaluated 
 
 
 
Chacko V, Kurikose S 20069-Histologically evaluated changes in the dental pulp 
following pulpotomy on premolar teeth that were to be extracted for orthodontic 
reasons with Mineral Trioxide Aggregate or Calcium hydroxide.. The teeth were 
extracted at 4 and 8-week intervals, fixed in 10% formalin and then kept in 5% 
nitric acid for 28 days for demineralization. Longitudinal sections were then 
prepared and viewed under light microscope. The pulps capped with MTA (at the 
end of 4 weeks and 8 weeks) showed dentin bridge formation, which was more 
homogenous and continuous with the original dentin when compared to the pulps, 
capped with calcium hydroxide. The pulpal inflammation was also less in the 
MTA group as compared to the calcium hydroxide group at the end of 4 and 8 
weeks. 
 
Duggal M, Al Ansary M 200611-compared pulpotomy technique using mineral 
trioxide aggregate, formocresol as a pulp dressing. Follow-up clinical (not blind) 
and radiographic (blind) assessments were undertaken every 6 months. Time 
elapsed between treatment and either 1) detection of pulpotomy failure 2) natural 
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exfoliation of tooth 3) patient's last visit for recall. Pulpotomy success rate = 
(number of teeth in which pulpotomy did not fail)/ (total number of treated teeth) 
100.  In total, 62 pulpotomized teeth were reviewed for analysis, 29 in the FC 
group and 33 in the MTA group. Treatment failure occurred in six teeth (one 
treated with MTA and five with FC) after a mean of 16 months (range, 4–30 
months). Pulpotomy success rates were 97% for MTA and 83% for FC. The mean 
follow-up time was 38months (range, 4.–74 months), in which there was no 
significant difference between test and control groups. No statistically significant 
difference was found in the success rates of MTA and FC  
 
 
Milnes AR, 200631 - discussed recent research about formaldehyde metabolism, 
pharmacokinetics and alleged carcinogenicity risk. Critical analysis of previous 
published results indicates that formaldehyde is probably not a potent human 
carcinogen under conditions of low exposure. Extrapolation of these research 
results to pediatric dentistry suggests an inconsequential risk of carcinogenesis 
associated with formaldehyde use in pediatric pulp therapy. Areas for further 
investigation are suggested. 
 
H. Neamatollahi, A. Tajik 200633 - compared clinical and radiographic success 
rates of pulpotomy in primary molars using Formocresol, Ferric Sulfate and 
Mineral Trioxide Aggregate (MTA). 135-second primary molars requiring 
pulpotomy treatment were selected from children between 3 and 6 years of age. 
All pulpotomized teeth were restored with amalgam. The subjects were monitored 
 43
periodically for 3 and 12 months. The clinical success rate of the MTA group was 
82.1% after one year, which was significantly less than the 100% observed in the 
other groups (P= 0.005). The highest and lowest radiographic success rates after 
one year were encountered in the formocresol (92.5%) and MTA (69.2%) groups 
respectively, which showed a significant difference (P=0.01). The success rate of 
the ferric sulfate group was 80.50%. According to authors MTA is not 
recommended as a pulpotomy medicament in primary teeth, but ferric sulfate may 
be acceptable as an alternative to formocresol. 
 
Percinoto, de Castro AM 200636 –compared clinical and radiographic 
examinations of calcium hydroxide and mineral trioxide aggregate (MTA) as 
pulpotomy medicament of primary molars.  Ninety primary molars were selected. 
The pulpotomy were performed in two sessions, using a corticosteroid/antibiotic 
solution as therapeutic dressing.  The samples were divided into two groups of 45 
teeth, in which the pulpal remains were protected with either calcium hydroxide 
paste (Group 1) or MTA (Group 2).  Radiographs were taken immediately and at 
3-, 6-, and 12-month follow-up appointments.  Three teeth in Group 1 failed after 
three months, while two cases failed after six months and one more failed at one 
year.  Two failures were found in Group 2 at the 12-month follow-up.  These 
results indicate that both materials may be utilized for pulpotomy in primary 
teeth. 
 
PengL, Ye L 200635-carried a evidenced based study using Medline, Cochrane 
Library, Embase, Science Citation Index, China National Knowledge 
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Infrastructure, reference lists, published literatures. Six studies met the inclusion 
criteria (giving a total of 381 teeth). Clinical assessments and radiographic 
findings of the MTA versus FC pulpotomy suggested that MTA was superior to 
FC in pulpotomy, resulting in a lower failure rate [relative risk, 0.32 (95% 
confidence interval, 0.11–0.90) and 0.31 (95% confidence interval, 0.13–0.74) 
respectively]. The results demonstrate that in primary molar teeth with vital pulp 
exposure caused by caries or trauma, a pulpotomy performed with MTA results in 
better clinically and radiographically observed outcomes. Fewer undesirable 
responses were recorded for MTA than when FC was used. The study supports 
the usage of MTA as a pulpotomy agent on primary molars. 
 
 
Srinivasan V, Patchett Cl et al 200645- the author states that International 
Agency for Research on Cancer has recently classified formaldehyde as 
carcinogenic to human beings. Since Buckley's Formocresol contains 19% 
formaldehyde in its full strength a safer alternative should be identified. After 
consideration of a review of extensively searched literature, a protocol and key 
points document have been developed by authors to assist clinicians in their 
treatment planning. Long-term studies with the highest level of evidence are 
suggested by authors to enable to identify acceptable alternatives for Formocresol. 
 
Aeinehchi M, Dadvand S et al 20071- compared the outcome of formocresol or 
mineral trioxide aggregate pulpotomy in primary molar teeth. 126 children (aged 
5–9 years) with carious primary teeth that required pulpotomy were selected. 
Following randomization, a standard pulpotomy preparation was undertaken, and 
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the coronal pulp removed and bleeding arrested. In the FC group, cotton balls, 
soaked in FC, were placed for 5 min, and then the pulp chamber was filled with 
Zonalin, a pulpotomy agent. In the MTA group, a 1-mm-thick paste of MTA was 
used as a pulpotomy agent. The crowns in both groups were restored with 
amalgam or glass ionomer. The teeth of 100 patients were evaluated and 
compared clinically and radiographically after 3 and 6 months. No signs of 
clinical failure were observed at the 3- and 6-month follow-up appointments in 
either group. At the 6-month follow-up, significantly more cases (P = 0.036) with 
root resorption were seen in the FC group; no cases of resorption occurred 
amongst the MTA cases. The surrounding tissue showed radiographic signs of 
post-treatment disease in four FC cases; none was seen in the MTA cases. Thus 
 after 6 months, pulpotomy with MTA was associated with fewer cases of root 
resorption and post-treatment disease. MTA appears to be a reliable alternative 
material for pulpotomy in primary molar teeth. 
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     Materials & Methods 
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The study was conducted on children who had attended the out patient department 
of Pediatric and Preventive dentistry, Ragas dental college, Chennai with good 
general health and no history of systemic illness or hospitalization. The Ethical 
Committee in Human Research of the Institution approved the study. Participation 
in the study was voluntary and a written consent was obtained from the parents or 
guardians. 
 
The study was performed on 100 mandibular molar teeth requiring pulpotomy 
treatment. Children between age four and six years of both the sexes were 
randomly selected and divided into Formocresol or MTA group.  In case a child 
with two molars needed pulpotomy, the second tooth was assigned to the alternate 
group. In case more than two were present requiring for treatment, random 
assignment was used.  
 
Histological assessment was done on lower deciduous canine teeth, which were 
undergoing serial extraction for interceptive orthodontic purpose. The teeth were 
divided into 2 groups. Pulpotomy was done on four teeth with Formocresol and 
another four teeth with MTA.   The teeth were extracted after 6months following 
pulpotomy procedure and histologically evaluated. Two freshly extracted carious 
teeth were taken as control. 
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The following materials were used in the study: 
 
o Local anesthetic-topical lignocaine hydrochloride jelly 
o Lignocaine hydrochloride solution-1: 80,000 adrenaline solution-Lignox 
o Disposable syringe with needle 
o Rubber dam 
o Dental floss 
o Saline 
o Spoon excavator. 
o Condenser. 
o Tweezer. 
o No: 330 straight fissure bur, round bur #8, #10 
o High speed hand piece with water coolant. 
o Sterile cotton pellets. 
o Diluted Formocresol. (20%v/v, Pharmadent remedies) 
o Zinc oxide eugenol restorative material-Deepak enterprises Mumbai 
o MTA -gray –product 8202- Angelus, Brazil 
o  Type 2 Glass ionomer cement-GC Fuji 2 corporation Tokyo 
o Stainless steel crown-3M company 
o Tapered fissure, flame shaped bur 
o No: 417 crimping plier 
o No: 114-Johnson contouring plier 
o Rubber wheel/ green stone- for finishing and polishing 
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o Cement mixing spatula, glass slab 
o Electronic digital caliper 
o Luting cement-type I Glass ionomer cement-G. C Corporation Fuji 2- 
Tokyo. 
o Articulating paper 
o X-ray viewer 
o Magnifying lens 
 
The clinical criteria for tooth selection 48, 22 
 
1. Teeth with deep carious lesion (radiographically the caries should be 
approximating to the pulp). 
2. Teeth should be restorable after completion of the procedure. 
3. Absence of symptoms indicative of advanced pulpal inflammation such as 
spontaneous pain or history of nocturnal pain 
4. Absence of clinical signs or symptoms suggesting a nonvital tooth such as 
suppurating sinus soft tissue swelling 
5. Absence of clinical radiographic signs of pulpal necrosis i.e. furcation 
involvement, periapical pathology, internal resorption, calcification in 
canal. 
6. Hemorrhage should stop within five minute from the amputated pulp 
stumps using a sterile pledget of moist cotton.  
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The study was done on lower right and left first and second molars for 
accessibility and accuracy. The pulpotomy procedure was then performed on the 
selected teeth as follows: 
The tooth was anesthetized and rubber dam isolation obtained. Soft debris, caries 
and unsupported enamel and dentin were removed with spoon excavator before 
opening the pulp chamber. Caries removal and coronal access obtained with # 330 
high-speed bur with water spray. Removal of the coronal pulp was done with a 
small sharp spoon excavator. Pulp chamber was then irrigated with saline to 
remove all debris. Hemostasis was obtained with a moistened cotton pellet gently 
pressed against the amputated pulp stumps in both the groups. 
In formocresol (control) group - cotton pellet dipped and squeezed in diluted 
formocresol (Pharmadent Remedies-1/5th dilution of Buckley formocresol) was 
placed in pulp chamber for 1 minute. The pulp chamber was then covered with a 
Zinc oxide Eugenol thick mix. The coronal part was restored with type II glass 
ionomer cement (GC Fuji 2) followed by stainless crown placement. The crown 
was luted with Type1GIC (GC Fuji 1) 
In the MTA (experimental) group - the MTA paste was obtained by mixing 3 
parts of powder with 1 part of water to obtain a putty consistency based on 
manufacturer’s instruction.  This mix was then placed in the pulp chamber with 
aid of plastic filling instrument.  A layer of Zinc oxide Eugenol thick mix was 
placed over MTA.  The coronal part of the tooth was restored with type II glass 
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ionomer cement (GC Fuji 2) followed by stainless crown placement. The crown 
was luted with Type 1 GIC (GC Fuji 1).  
The procedure for stainless steel crown placement is as follows. The stainless 
steel crown was selected based on the mesiodistal width of the tooth to be 
crowned using digital caliper. Occlusal reduction of 1.5-2 mm was done using 
flame shaped bur. 1mm depth grooves were placed initially to make reduction 
accurate. Using tapered fissure bur proximal reduction was done by moving the 
bur in bucco-lingual direction. Using a finishing bur all the line angles were 
rounded. The stainless steel crown was then trial fitted. The excess material was 
cut with curved crown scissors. The crown was then crimped at the gingival 
margin. The margins were finished with green stone. After isolation of teeth with 
cotton rolls the crown was cemented with type I glass ionomer cement (GC-Fuji-
1). After cementation immediate postoperative radiograph were taken for future 
review. 
The patients were recalled after 3month, 6months, 9months and 12 months 
respectively and evaluated clinically and radiographically. The radiographs were 
evaluated by two examiners at follow up who were blind to the group and a 
consensus was reached.  
Teeth were considered to be clinically successful in the absence of 48, 22, 6 
o Spontaneous pain 
o Draining fistula 
o Swelling or abscess 
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o Mobility 
o Premature exfoliation. 
 
Teeth were considered to be radiographically successful in the absence of 48,22,6 
o Abnormal root resorption 
o Internal root resorption. 
o Furcation involvement 
o Periapical bone destruction. 
 
Pulp canal obliteration and pulp calcification was not regarded as a failure 2, 14 
Histological study was done with the help of Oral Pathology department, Ragas 
Dental College. The extracted teeth were all fixed in buffered formalin and 
decalcified in 3% trichloroacetic acid. Buccolingual sections were processed and 
prepared for microscopic examination under 4X, 10X, and 40X magnification.  
An examiner who was blind to the pulpotomy medicaments evaluated the slides.  
The histological features that were evaluated were odontoblastic integrity, pulp 
inflammation, pulp calcification, dentine bridge formation and presence of pulp 
stone. 
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Instruments used 
 
 
Materials used 
 
 
Stainless steel crown armamentarium 
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PULPOTOMY TECHNIQUE 
 
Prep - Op and Rubber Dam Isolation 
 
 
 
 
 
 
 
 
Soft Debris and Unsupported Enamel Removed With Spoon Excavation 
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Roof of the Pulp Chamber Exposed 
 
 
 
 
 
 
 
 
Sterile Cotton Pellet Placed For Hemostasis 
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  Pulpotomized Site after Placement of Formocresol 
 
 
 
 
 
 
 
 
 
Placement of ZNOE over Formocresol Pulptomized Site 
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MTA Placed Immediately After Hemostasis Obtained with Cotton Pellet 
 
 
 
 
 
 
GIC – Type II Placed as a Coronal Filling 
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CROWN PREPARATION FOR STAINLESS STEEL CROWN 
 
Occlusal crown reduction 
  
 
 
 
 
Proximal crown reduction  
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Completed crown preparation  
 
 
 
 
 
 
 
Completed S.S. Crown in Occlusion 
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     Observations & Results 
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The study was conducted on 63 children of 4-6 years age who were selected from 
the patients attending the Department of Pediatric and Preventive Dentistry, Ragas 
Dental College Chennai. 100 teeth requiring pulpotomy treatment in children 
between age four and six years of both the sexes were randomly selected and 
divided into two groups of 50 each, Formocresol and MTA group. After applying 
the pulpotomy medicament, Formocresol or MTA, the coronal part of both the 
group was restored with Zinc oxide Eugenol cement and Glass ionomer cement 
type 2. Stainless steel crown was placed on the same appointment. The teeth were 
evaluated at 3, 6, 9, 12-month intervals clinically and radiographically by two 
examiners who were blinded to study groups. 
 
Table-1 represents distribution of sample. The teeth were lost to follow up 
because of transfer of parent’s work to a different city.  In Formocresol group 50 
teeth were treated at the start of the study. Two teeth were lost to follow up at the 
end of 9 months and another two teeth were lost to follow up at end of 12 months. 
Thus, 46 teeth were evaluated clinically and radiographically at the end of 12 
months. In MTA group, 50 teeth were treated at the start of the study. Three teeth 
were lost to follow up at end of 9 months. Thus there were totally 47 teeth for 
evaluation clinically and radiographically at end of 12 months.  
 
Table-2 represents clinical evaluation of both the groups at 3, 6, 9, 12-month 
interval. The success criteria were taken as absence of pain, fistula, mobility, 
premature exfoliation of teeth. On 3, 6-month clinical evaluation, Formocresol 
group did not show any clinical signs and symptoms with the success rate of 
 62
100%. Four teeth showed grade –1mobility at 9 months .The success rate at end 
of 9 months was 91.6%. The same clinical symptoms were noted at 12 month in 
the same four teeth. Two teeth were lost to follow up with success rate of 91.3% 
clinically at end of 12 months. In MTA group no clinical signs and symptoms 
were noted from 3 to 12 months. The clinical success rate was 100%. 
 
Table-3 represents radiographic evaluation of both the groups at 3, 6, 9, 12-month 
interval. The success criteria were taken as absence of abnormal root resorption, 
Inter radicular radiolucency, periodontal ligament widening, periapical 
radiolucency, and internal root resorption. 
 
In radiographic evaluation no failure was noted in both the groups at 3 months 
interval. In 6-month evaluation five teeth in Formocresol group showed 
periodontal ligament widening, out of which two teeth had associated 
interradicular radiolucency. The radiographic success rate was, 90% with 
Formocresol at end of 6-month interval. In MTA group no failure was noted 
radiographically, success being 100% at end of 6 months.  
 
At 9-month evaluation, in Formocresol group, additional four teeth had 
periodontal ligament widening, totally being 9 teeth, out of which five had 
associated interradicular radiolucency and one had associated abnormal root 
resorption. The radiographic success rate was 81.25% at the end of 9 months.  In 
MTA group at 9-month evaluation two teeth had periodontal ligament widening. 
The radiographic success rate was 95.74%. 
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In 12-month interval, in Formocresol group, additional one tooth had periodontal 
ligament widening, totally being ten teeth, out of which seven had associated 
inter- radicular radiolucency and two teeth had associated abnormal root 
resorption. The success rate of Formocresol at end of 12 months was 78.26%. In 
MTA group at 12-month evaluation in the same two teeth as in previous 
evaluation, periodontal ligament widening was noted and out of which one of the 
teeth had additional inter radicular radiolucency. The radiographic success rate of 
MTA at end of 12 months was 95.74%. 
 
The success rate at end of 12 months evaluation - 
Clinically in Formocresol group - 91.3% 
Clinically in MTA group  - 100% 
Radiographically in Formocresol group- 78.26% 
Radiographically in MTA group - 95.74% 
Overall success rate in Formocresol group  84.78% 
Overall success rate In MTA group - 97.87% 
 
With the above results test of significance using Chi Square was carried out 
between the two groups. Statistically analysis revealed significant difference in 
mobility between two groups at end of 12 month (p ≤ 0.05). Significant 
differences were noted radiographically with respect to periodontal ligament 
widening (p≤0.01 level) and inter - radicular radiolucency (p≤0.02 level) between 
two groups at end of 12 month. Other parameters were not significant between the 
two groups. 
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Pulp canal obliteration was noted with MTA at end of 12 months. A case of 
replacement resorption was noted with Formocresol at 12 month. Both pulp canal 
obliteration2, 14 and replacement resorption were not considered as failure of 
treatment. Thus they were not included in statistical analysis of the study. 
 
Histological evaluation: 
In Formocresol group, increased inflammatory cells were found in pulp. 
Odontoblastic layer was not intact throughout the dentine pulp complex. . Pulp 
stones were isolated and scattered. Pulp stones were less in number compared to 
MTA group. Dentine Bridge was not seen. A zone of atrophy was noted in 
radicular portion of pulp. 
 
In MTA group, odontoblastic layer integrity was well maintained. Numerous pulp 
calcifications-pulp stones were seen. These calcific masses were found isolated. 
The amounts of pulp stones were more than Formocresol group. The pulp was 
hyperemic, yet less inflammatory cells were seen comparing Formocresol group. 
Reversal line/ resting line were noted.  An amorphous eosinophilic layer of neo 
dentine formation with less dentinal tubules was seen in the coronal portion of 
pulp. This could be considered as Dentine Bridge, which represents the 
pulpotomized regenerating site. 
 
 In control group in which freshly extracted teeth without placement of 
medicaments, complete atrophy of pulpal space was noted.  
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FORMOCRESOL PULPOTOMY  
 
Pre-op 
 
 
 
 
Immediate Post-Op 
 
 
 
 
3-month 
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6-month 
 
 
 
 
9-month 
 
 
 
 
12-month 
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MTA PULPOTOMY 
 
Pre-op 
 
 
 
 
Immediate Post-Op 
 
 
 
 
3-month 
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6-month 
 
 
 
 
9-month 
 
 
 
 
12-month 
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INCREASED ROOT RESORPTION 
 
 
Base line (formocresol) 
 
 
 
 
 
 
 
 
 
 
Post Op - 12 month 
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INTER RADICULAR RADIOLUCENCY 
 
 
Base line (formocresol) 
 
 
 
 
 
 
 
 
 
 
Post Op – 6 month 
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PULP CANAL OBLITERATION 
 
 
Base line (MTA) 
 
 
 
 
 
 
 
 
 
 
Post Op - 12 month 
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PERIODONTAL LIGAMENT WIDENING 
 
 
Base line (formocresol) 
 
 
 
 
 
 
 
 
 
Post Op - 6 month 
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REPLACEMENT RESORPTION 
 
 
Base line (formocresol) 
 
 
 
  
 
 
 
Post Op - 12 month 
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FORMOCRESOL (10X) - ODONTOBLAST, PULP STONE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Integrity of odontoblast not maintained. Round hematoxilic masses are pulp 
stones 
 
 
MTA (10X) - ODONTO BLASTIC LAYER MAINTAINED 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Integrity of odontobalst maintained throughout the dentine pulp complex. 
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FORMOCRESOL (4X) – Integrity of Odontoblast not maintained,  
Pulp stone seen, Pulp hyperemic 
 
 
 
 
Integrity of odontoblast is not maintained throughout dentine pulp complex. 
Pulp stones are found as isolated discrete masses. Pulp is hyperemic with dilated 
blood vessels. 
 
 
MTA - 10X PULP STONE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pulp stones are large, discrete, isolated and more in number 
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FORMOCRESOL - NO EVIDENCE OF DENTINE BRIDGE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MTA - EVIDENCE OF DENTINE BRIDGE 
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PULP DEGENERATION - CONTROL TEETH 
 78
Table-1 
 
DISTRIBUTION OF SAMPLE DURING THE STUDY 
 
Evaluation 
 
Formocresol 
 
MTA 
 
Intervals 
 
Total 
 
D 
 
E 
 
Total 
 
D 
 
E 
3month 50 30 20 50 27 23 
6month 50 30 20 50 27 23 
9month 48 28 20 47 25 22 
12month 46 27 19 47 25 22 
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Table-2 
CLINICAL EVALUATION  
Values given in parenthesis are success percentage. 
  
3month 3month 6month 6month 9month 9month 12month 12month
 
P Value 
 
 FC MTA FC MTA FC MTA FC MTA 
 
Pain Present 0 0 0 0 0 0 0 0 
     ≥ 0.05 
 Absent 
50 
(100%) 
50 
(100%) 
50 
(100%) 
50 
(100%) 
48  
(100%) 
47 
(100%) 
46   
(100%) 
47 
(100%) 
 
Fistula Present 0 0 0 0 0 0 0 0 
≥ 0.05 
 Absent 
50 
(100%) 
50 
(100%) 
50 
(100%) 
50 
(100%) 
48  
(100%) 
47 
(100%) 
46   
(100%) 
47 
(100%) 
 
Abscess Present 0 0 0 0 0 0 0 0 
≥ 0.05 
 Absent 
50 
(100%) 
50 
(100%) 
50 
(100%) 
50 
(100%) 
48  
(100%) 
47 
(100%) 
46   
(100%) 
47 
(100%) 
 
Mobility Present 0 0 0 0 4 0 4 0 
≤ 0.05 
 Absent 
50 
(100%) 
50 
(100%) 
50 
(100%) 
50 
(100%) 
44 
(91.6%) 
47 
(100%) 
42  
(91.3%) 
47 
(100%) 
 
Premature 
Exfoliation Present 0 0 0 0 0 0 0 0 
≥ 0.05 
 Absent 
50 
(100%) 
50 
(100%) 
50 
(100%) 
50 
(100%) 
48  
(100%) 
47 
(100%) 
46   
(100%) 
47 
(100%) 
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Table-3 
Radiographic Evaluation 
Values given in parenthesis are success percentage. 
  3mont 3month 6month 6month 9month 9month 12month 12month 
 
P Value 
  FC MTA FC MTA FC MTA FC MTA  
Abnormal root 
resorption 
Present 
 
0 
 
0 
 
0 
 
0 
 
1 
 
0 
 
2 
 
0 
 
 
≥ 0.05 
 Absent 
50 
(100%) 
50 
(100%) 
50 
(100%) 
50 
(100%) 
47    
(97.9%) 
47   
(100%) 
44   
(95.6%) 
47     
(100%) 
 
Inter radicular 
radioluscency 
Present 
 
0 
 
0 
 
2 
 
0 
 
5 
 
0 
 
7 
 
1 
 
 
≤ 0.02  
 Absent 
50 
(100%) 
50 
(100%) 
48  
(96%) 
50 
(100%) 
43    
(89.5%) 
47   
(100%) 
39 
(84.78%) 
46   
(97.8%) 
 
Periodontal 
ligament 
widening Present 
0 
 
0 
 
5 
 
0 
 
9 
 
2 
 
10 
 
2 
 
 
≤0.01  
 Absent 
50 
(100%) 
50 
(100%) 
45  
(90%) 
50 
(100%) 
39  
(81.25%) 
45 
(95.7%) 
36   
(78.2%) 
45  
(95.7%) 
 
Periapical 
Radioluscency Present 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
≥ 0.05 
 Absent 
50 
(100%) 
50 
(100%) 
50 
(100%) 
50 
(100%) 
48       
(100%) 
47    
(100%) 
46     
(100%) 
47     
(100%) 
 
Internal Root 
resorption Present 0 0 0 0 0 0 0 0 
≥ 0.05 
 Absent 
50 
(100%) 
50 
(100%) 
50 
(100%) 
50 
(100%) 
48        
(100%) 
47    
(100%) 
46     
(100%) 
47     
(100%) 
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Clinical Comparison of Success Rate between Formocresol and MTA at 3 
Month Intervals 
 
50
60
70
80
90
100
3 6 9 12
FC
MTA
 
Radiographic Comparison of Success Rate between Formocresol and MTA 
at 3 Month Intervals 
 
50
60
70
80
90
100
3 6 9 12
FC
MTA
 
 
 
Success Rate between Formocresol and MTA at the end of 12 Month  
 
 
50
60
70
80
90
100
CLINICAL RADIO OVER ALL
FC
MTA
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       Discussion  
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The study was conducted on   63 children who were selected from among the 
patients attending the Department of Pediatric and Preventive Dentistry, Ragas 
Dental College Chennai. 100 teeth requiring pulpotomy treatment in children 
between ages four and six years of both the sexes were randomly selected to 
either of the group, Formocresol or MTA group. 
 
Preservation of primary and young permanent teeth remains one of the main 
challenges of a pediatric dentist. Premature loss of primary teeth leads to space 
loss, causing deficiency of arch length. Other objectives being, to maintain the 
integrity of primary dentition, to prevent aberrant tongue habits, mastication, 
esthetics and occlusion. Pulpal therapy is one of the ways in which pulpally 
exposed teeth due to caries or trauma can be saved. Among the various procedures 
pulpotomy has gained wider acceptance. 
 
Formocresol usage has been criticized because of the following reports. Addition 
of cresol to formaldehyde caused cytotoxic effects and proved to be 40 times 
more toxic than cresol (Jeng HW, Feigal 1987). Formocresol has been 
demonstrated diffusing into pulp, dentin, periodontal ligament, cementum and 
bone surrounding the apexes of pulpotomized teeth (Cwikla 1972) 36. There is 
fear of damage to the succedaneous tooth, enamel defects on the permanent 
successors 30, positional alterations of the underlying permanent tooth bud 
(Rolling I, Poulsen S 1978), necrosis of crestal bone and overlying gingival tissue 
(Cambruzzi and Greenfield 1983) and necrosis of crestal bone due to the usage of 
formocresol in permanent teeth (Kawaikami et al 2003), premature exfoliation of 
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primary molar 18 have been reported.  .  They could inhibit macrophage function 
and modulate immune and inflammatory responses in dental pulp and periapical 
tissues. Kidney is the most vulnerable organ to damage from formaldehyde 
36.Mutagenicity has been demonstrated in studies on Drosophila (Kaplan 1948), 
Escherichia coli (Nishioka 1973), Neurospora (Jenson et al. 1951). There have 
also been reports that exposure of formaldehyde leads to unstable DNA-protein 
links which can cause clastogenic lesions, sister chromatid changes, chromosomal 
aberrations. The International Agency for Research on Cancer (IARC) of the 
World Health Organization in June 2004 stated that there was sufficient evidence 
that formaldehyde causes nasopharyngeal cancer, limited evidence that it causes 
nasal and paranasal sinus carcinoma and strong but not sufficient evidence that 
formaldehyde causes leukemia in humans. Buckley’s formocresol was mutagenic 
for one patient in an in vivo study to lymphocyte cultures obtained from the 
peripheral blood 50, raising doubt about the desirability of its use for pulpotomies 
in children. 
 
There are also reports stating that amount of Formocresol usage is safe. 
Formaldehyde is found in the air we breathe, the water we drink and the food we 
eat.  Although daily intake from food is difficult to evaluate, the World Health 
Organization has estimated it at 1.5-to 14-mg/ day (mean 7.8 mg/day). The 
estimated dose of formaldehyde associated with one pulpotomy procedure, 
assuming a 1:5 dilution of formocresol placed on a number 4 cotton pellets that 
has been squeezed dry, is 0.02 to 0.1 mg. Thus there is no inconsequential risk of 
carcinogenesis associated with formaldehyde use in pediatric pulp therapy 
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31.Formocresol was selected as the control group, since it is still considered the 
gold standard in primary tooth pulp therapy.  The 1minute application of 
Formocresol is found to be as effective as 5 minutes (Garcia Godoy 1982). 
Results of the various studies ( Loos &Hans 1971, Morawa 1974, Straffon L.H ) 
have found that  1: 5 dilution (20% concentration) achieves desired cellular 
response and faster recovery of the affected cells. Thus in the present study 
diluted Formocresol at 20% dilution (pharmadent laboratories) at 1 minute 
application was followed. The British Society of Paediatric Dentistry guidelines 
2006, when describing the procedure for a pulpotomy, suggest that one of the 
medicaments that can be chosen is a 1 in 5 dilution of Buckley’s FC solution 
although they do add that routine use of the FC pulpotomy “may be imprudent 
given the availability of effective alternatives”. 
 
The need for search for newer medicaments led to usage of Mineral tri oxide 
aggregate as a pulpotomy agent as introduced by Torabinejad M 1993. Its main 
components are tricalcium silicate, tricalcium aluminate, tricalcium oxide, and 
silicate oxide.  Bismuth oxide also has been found in MTA, which gives the 
material radiopaque characteristics 7. It is available as gray and white. Gray 
differs with the presence of ferrous aluminium silicate. Torabinejad et al mixed 
MTA with water and reported that the material’s pH rose within three hours (from 
10.2 to 12.5), showing evidence of an antimicrobial effect on some facultative 
anaerobic bacteria, due to the highly alkaline pH16. 
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The mechanism of action of MTA is similar to that of calcium hydroxide and 
Portland cement 42. Calcium oxide, one of its components, is converted into 
calcium hydroxide when the paste is mixed with water.  This in turn dissociates 
itself into Ca and OH ions upon contact with the tissue fluids.  The calcium ions 
react with the carbon dioxide in the tissues, producing calcite granulations.  
Fibronectin accumulates with these granulations, which allows cellular adhesion 
and differentiation to occur.  A hard tissue bridge formation result 16, 17. The MTA 
meets available currently in the market under the corporate names of MTA 
ProRoot® (Dentsply) and MTA-Angelus® (Angelus). The brands of MTA 
evaluated do not interfere in the cytokine response by M1 or M2 macrophages of 
the bacteria tested 39. In the present study MTA Angelus was used. 
 
The purpose of the study is   to evaluate and compare MTA and Formocresol as a 
pulpotomy medicament by clinical and radio graphic assessment and to assess the 
histological features of MTA and Formocresol as pulpotomy medicaments. 
 
The study was done on mandibular molar for accessibility and accuracy .The 
selection is based on criteria by previous studies 48, 22. In Formocresol group, 1-
minute application of 20% dilution was used. In MTA group medicament was 
placed on the pulp chamber based on the manufacture’s instruction. Following 
pulpotomy all the teeth in the present study were restored with stainless steel 
crown on the same appointment.  In a retrospective study comparing the success 
rates of formocresol pulpotomy in primary molars restored with stainless steel 
crowns (SSC) to those restored with amalgam (AM) 15, found pulpotomized 
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primary molars restored with SSC had more success 13. Postoperative radiograph 
was taken on the same appointment as a reference. The patients were recalled 
after 3, 6,9,12 months intervals. Two examiners clinically and radiographically 
evaluated the teeth. The evaluation is based on the criteria of previous studies 48, 
22, 6 
 
The clinical success criteria were taken as absence of pain, fistula, mobility, 
premature exfoliation of teeth. On 3, 6-month clinical evaluation, Formocresol 
group did not show any clinical signs and symptoms with the success rate of 
100%. Four teeth showed grade –1mobility at 9 months .The success rate at end 
of 9 months was 91.6%. The same clinical symptoms were noted at 12 month in 
the same four teeth. Two teeth were lost to follow up at the end of 12-month 
review; the clinical success rate was 91.3%. The probable reason of failure may 
be due to reversible fixative effect of formocresol, and irritative pH, chemical and 
physical effects of ZOE on pulp tissue, which might have caused grade-1 mobility 
in Formocresol group. In MTA group no clinical signs and symptoms were noted 
from 3 to 12 months. The clinical success rate was 100%. 
 
The radiographic success criteria were taken as absence of abnormal root 
resorption, Inter radicular radiolucency, periodontal ligament widening, periapical 
radioluscency, and internal root resorption. In radiographic evaluation no failure 
was noted in both the groups at 3 months interval, success rate was 100% for both 
the groups.  The radiographic success at end of 6-month interval was 90% for 
Formocresol and 100% for MTA. . The radiographic success rate at end of 9 
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month was 81.25% for Formocresol, 95.74% for MTA. In 12-month interval, 
success rate of Formocresol was 78.26% and 95.74% for MTA. The common 
radiographic failure in the present study in formocresol group was periodontal 
ligament widening and inter radicular radioluscency. The probable reason may be 
due to fixative effect of formocresol, ability of vapours to escape via apical 
foramen, periodontal ligament, cementum, alveolar bone 36, 18 (Cwikla 1972). The 
radiographic finding of periodontal ligament widening and inter radicular 
radioluscency seen in two cases of MTA as failure can be attributed to 
misdiagnosis of inflammation in the radicular pulp prior to treatment 14. Yet the 
teeth did not show any clinical signs of failure. These findings are comparable 
with other studies6, 36. 
 
The greater success rate of MTA is observed in the present study when compared 
to Formocresol pulpotomy clinically (MTA group 100% vs. 91.3%of 
Formocresol), radiographically (MTA group 95.74% vs. 78.26% Formocresol 
group) and overall (MTA group 97.87% vs. 84.78% Formocresol group). 
Significant difference in mobility between two groups at end of 12 month 
(p=0.05), and radiographically with respect to periodontal ligament widening 
(p=0.01 level) and inter radicular radioluscency (p=0.02 level) between two 
groups at end of 12 month were observed. This can be attributed to 
biocompatibility, and sealing ability of MTA cement 3 compared to Formocresol. 
In vitro toxicity of primary teeth pulpotomy agents based on MTT cell 
proliferation test and Neutral Red uptake colorimetric assays has ranked as: 
Formocresol>diluted Formocresol >ferric sulfate>calcium hydroxide>MTA.  
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MTA was the less cytotoxic pulpotomy agent. 28. Thus MTA is a biocompatible 
material, which promotes hard tissue formation. 
 
The results of the study are comparable to Eidelmann et al 2005 14 [97% success 
for MTA (1 failure) and 83% for FC (5 failures], S.E. Jabbarifar 2004 21 [93.75 % 
success rate for MTA and 90.6 % in FC group after one year], Aeinehchi et al M 
2007 1[fewer cases of root resorption and post-treatment disease in MTA group]. 
The results of the present study done with MTA angelus closely coincide with 
previous studies done with MTA, Dentsply, Tulsa Dental, and Tulsa 14, 40,2, 
21,12,26,32.  The result of study does not agree with H. Neamatollahi 33 study where 
radiographic success of MTA pulpotomy was poorer 69.2% when compared to 
Formocresol 92.5%. This could possibly because of a smaller sample size (15 
cases) or the wider age range of the patients (5 to 12 years), which can reduce the 
validity, and reliability of the results in their study.  
 
Formocresol has been undergoing a process of rejection for several decades but 
there is still controversy over recommendations for its use. The recent Scottish 
Intercollegiate Guidelines Network guideline 2005 recommended that FC “should 
be replaced by alternative materials for pulpotomy procedures in primary teeth”. 
In meta analysis of studies of Formocresol versus MTA, Peng L et al 2006 35 
suggested that MTA was superior to FC in pulpotomy, clinically and 
radiographically resulting in a lower failure rate [relative risk, 0.32 (95% 
confidence interval, 0.11–0.90) and 0.31 (95% confidence interval, 0.13–0.74) 
respectively]. 
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Pulp canal obliteration as a result of odontoblastic activity suggests that tooth is 
retaining its vitality and therefore is not regarded as failure 14, 2.  An unusual 
single case of replacement resorption was noted with Formocresol at the end of 12 
month. Replacement resorption was not taken as failure because it’s also an 
accelerated odontoblastic activity.  
Histologically the sections were examined for inflammation, odontoblastic layer 
integrity, pulp calcifications, dentine bridge formation. Histological examination 
of Formocresol showed increased number of inflammatory cells when compared 
to MTA, a zone of atrophy at the radicular portion with no dentine bridge 
formation, which confirms that formocresol, has no reparative ability and its 
action limited as a fixative agent. Histological examination of MTA section 
showed dentine bridge formation with more of neo dentine like tissue with less 
number of dentinal tubules. This zone was found at the coronal pulpotomy site 
where the medicament was placed indicating regenerative nature of the material. 
In vitro investigation has demonstrated the ability of MTA to stimulate cytokine 
release from bone cells, indicating that it actively promotes hard tissue formation 
rather than being inert 42 (Koh ET, Pitt Ford TR 1995, N.K Sarkar-IADR 2002.).  
Mineral trioxide aggregate maintains the integrity of the pulp 10. Odontoblastic 
layer integrity was well maintained and was regular throughout the pulp dentine 
complex. Pulp calcifications were found in large numbers. Odontoblastic layer 
integrity and pulp calcification findings are consistent with Agamy etal, Caicedo 
study 2, 6 .The pulp inflammation in MTA group was similar to Chacko findings 9. 
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Dentine bridges formed could be as a result of pulp irritation and/or inflammation, 
or alternatively due to a stimulus from the material placed over the exposed pulp. 
Histological studies done in dogs, cats and rabbits, have also demonstrated hard 
tissue formation after placement of MTA 27, 29, 38,47,3 
In the present study in MTA slides large number of discrete calcification were 
seen suggesting a close relation between nerve fibers and odontoblastic cell 
differentiation suggesting repair of pulpotomized site which is similar to Inoue H 
study20 where close contact between fibroblast-like cells/osteoblast-like cells and 
nerve terminals at the calcification front in the early healing process after calcium 
hydroxide pulpotomy was observed.  
In the present study an evaluation criteria could not be done for histological 
assessment because of the smaller sample size and difficulty in getting extracted 
teeth after successful pulpotomy. 
In the present study MTA has grater success rate at end of 12 months [clinically 
(100% MTA vs. 91.3%Formocresol), radiographically (95.74% MTA vs. 78.26% 
Formocresol) and Overall (97.87%MTA vs. 84.78%)] when compared to 
formocresol. The study is limited to a 12-month review and it requires complete 
follow up till the eruption of sucedaneous tooth.       
 
 92
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Summary & Conclusion 
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This in vivo study was carried out on 100 deciduous mandibular molar found in 
63 children aged 4 to 6 years .The aim of the study was to evaluate and compare 
MTA and Formocresol as a pulpotomy medicament by clinical and radio graphic 
assessment and to assess the histological features of MTA and Formocresol as a 
pulpotomy medicament. The study was carried out with evaluation done clinically 
and radiographically at 3, 6, 9, 12-month intervals. 
 
Significant difference in mobility (p≤0.05), Periodontal ligament widening 
(p≤0.01 level) and inter - radicular radioluscency (p≤0.02 level) were seen 
between two groups at end of 12 month. Other parameters were not statistically 
significant between the two groups.  
 
Histological examination done in deciduous mandibular canine showed dentine 
bridge formation in MTA sections following 6 months after pulpotomy. The 
integrity of odontoblast was well maintained and numerous pulp calcifications 
were found. These findings confirm the reparative ability of MTA. 
 
The following conclusions can be drawn from the present study. 
o MTA is superior to Formocresol clinically 
o MTA is superior to Formocresol radiographically 
o Histological analysis showed better reparative ability with hard tissue 
barrier formation with MTA compared to Formocresol. 
 
Thus it can be concluded that MTA has biological characteristics to be used as 
pulpotomy medicament in deciduous teeth. 
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Annexure I: Ethics Committee Approval 
 
 
 
The institutional review board Consisting of Chairman, Dr.S.Ramachandran, 
Members of board  -Heads of all the Department, Advocate Mr. Kamalakannan, 
Social worker Mr. KK Raman, General Medicine - Dr. U V Ramakrishnan MD 
and General Surgery - Dr. Parthasarathy MS have approved the study titled 
Comparative Evaluation of Formocresol and Mineral Trioxide Aggregate as a 
Pulpotomy Agent. 
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Ragas Dental College and Hospital, Chennai 
Department of Pedodontia and Preventive Dentistry 
 
As per oral examination of your child’s teeth, he/she requires pulp treatment with 
Formocresol/MTA for badly decayed teeth, which will be performed on chair side 
under Local Anesthesia and would require intra oral periapical radiograph for the 
same. The child will be followed at a regular recall once in 3 months, which 
requires your kind cooperation. 
Ragas Dental College and Hospital. 
                                     
 
 
 Informed consent 
 
I. ………………………Father/mother of master/miss…………….. 
Herewith grant permission to participate in the above-mentioned study. I 
voluntarily give my consent to do the treatment. 
                                                                 
                                                                         Signature& name 
Date 
Place. 
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PROFORMA 
 
Name of the child 
 
Age                               Sex                                Date of birth 
 
Parents Name 
 
Address 
 
 
Phone number 
 
Chief complaint 
 
History of Present illness 
 
Past medical history 
 
Past dental History 
 
Parental dental History 
 
Diet Diary 
 
Extra oral examination: 
 
Inspection- 
 
Palpation 
 
Swelling/ ulcer 
 
Lymph node 
 
TMJ 
 
Intra oral Examination 
   
                        Soft tissue examination-lip 
                                                               Buccal Mucosa 
                                                               Floor of mouth 
                                                               Frenum 
                                                               Tongue 
                                                                Alveolar mucosa 
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                Hard tissue examination 
                                       Teeth          Decay 
                                                          Missing 
                                                          Filling 
 
                                        Calculus/ stain 
 
                                        Occlusion 
 
  Provisional Diagnosis 
 
  Investigations- Radiographs-Intra Oral periapical radiograph 
  
 
  Treatment Plan 
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Master Chart 
3 months evaluation 
 
S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 
1 FC 84 N N N N N N N N N 26 FC 74 N N N N N N N N N 
2 FC 75 N N N N N N N N N 27 FC 84 N N N N N N N N N 
3 FC 74 N N N N N N N N N 28 FC 85 N N N N N N N N N 
4 FC 84 N N N N N N N N N 29 FC 74 N N N N N N N N N 
5 FC 85 N N N N N N N N N 30 FC 75 N N N N N N N N N 
6 FC 74 N N N N N N N N N 31 FC 74 N N N N N N N N N 
7 FC 84 N N N N N N N N N 32 FC 84 N N N N N N N N N 
8 FC 85 N N N N N N N N N 33 FC 85 N N N N N N N N N 
9 FC 74 N N N N N N N N N 34 FC 84 N N N N N N N N N 
10 FC 75 N N N N N N N N N 35 FC 85 N N N N N N N N N 
11 FC 74 N N N N N N N N N 36 FC 84 N N N N N N N N N 
12 FC 74 N N N N N N N N N 37 FC 75 N N N N N N N N N 
13 FC 85 N N N N N N N N N 38 FC 74 N N N N N N N N N 
14 FC 84 N N N N N N N N N 39 FC 85 N N N N N N N N N 
15 FC 74 N N N N N N N N N 40 FC 74 N N N N N N N N N 
16 FC 75 N N N N N N N N N 41 FC 84 N N N N N N N N N 
17 FC 74 N N N N N N N N N 42 FC 85 N N N N N N N N N 
18 FC 85 N N N N N N N N N 43 FC 74 N N N N N N N N N 
19 FC 84 N N N N N N N N N 44 FC 84 N N N N N N N N N 
20 FC 74 N N N N N N N N N 45 FC 75 N N N N N N N N N 
21 FC 85 N N N N N N N N N 46 FC 74 N N N N N N N N N 
22 FC 84 N N N N N N N N N 47 FC 84 N N N N N N N N N 
23 FC 85 N N N N N N N N N 48 FC 75 N N N N N N N N N 
24 FC 75 N N N N N N N N N 49 FC 85 N N N N N N N N N 
25 FC 84 N N N N N N N N N 50 FC 84 N N N N N N N N N 
    
C1 - Pain       R1 - Abnormal Root Resorption 
C2 - Fistula       R2 - Inter Radicular Radiolucency 
C3 - Abscess      R3 - Periodontal Ligament Widening 
C4 - Mobility      R4 - Periapical Radiolucency 
C5 - Premature Exfoliation     R5 - Internal Root Resorption 
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Master Chart 
3 months evaluation 
 
S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 
51 MTA 75 N N N N N N N N N 76 MTA 84 N N N N N N N N N 
52 MTA 84 N N N N N N N N N 77 MTA 75 N N N N N N N N N 
53 MTA 74 N N N N N N N N N 78 MTA 85 N N N N N N N N N 
54 MTA 85 N N N N N N N N N 79 MTA 84 N N N N N N N N N 
55 MTA 74 N N N N N N N N N 80 MTA 75 N N N N N N N N N 
56 MTA 75 N N N N N N N N N 81 MTA 74 N N N N N N N N N 
57 MTA 74 N N N N N N N N N 82 MTA 75 N N N N N N N N N 
58 MTA 84 N N N N N N N N N 83 MTA 74 N N N N N N N N N 
59 MTA 75 N N N N N N N N N 84 MTA 85 N N N N N N N N N 
60 MTA 74 N N N N N N N N N 85 MTA 84 N N N N N N N N N 
61 MTA 74 N N N N N N N N N 86 MTA 75 N N N N N N N N N 
62 MTA 85 N N N N N N N N N 87 MTA 84 N N N N N N N N N 
63 MTA 74 N N N N N N N N N 88 MTA 74 N N N N N N N N N 
64 MTA 75 N N N N N N N N N 89 MTA 84 N N N N N N N N N 
65 MTA 84 N N N N N N N N N 90 MTA 85 N N N N N N N N N 
66 MTA 74 N N N N N N N N N 91 MTA 75 N N N N N N N N N 
67 MTA 75 N N N N N N N N N 92 MTA 84 N N N N N N N N N 
68 MTA 85 N N N N N N N N N 93 MTA 74 N N N N N N N N N 
69 MTA 74 N N N N N N N N N 94 MTA 75 N N N N N N N N N 
70 MTA 75 N N N N N N N N N 95 MTA 74 N N N N N N N N N 
71 MTA 84 N N N N N N N N N 96 MTA 84 N N N N N N N N N 
72 MTA 84 N N N N N N N N N 97 MTA 75 N N N N N N N N N 
73 MTA 75 N N N N N N N N N 98 MTA 84 N N N N N N N N N 
74 MTA 74 N N N N N N N N N 99 MTA 85 N N N N N N N N N 
75 MTA 85 N N N N N N N N N 100 MTA 75 N N N N N N N N N 
 
C1 - Pain       R1 - Abnormal Root Resorption 
C2 - Fistula       R2 - Inter Radicular Radiolucency 
C3 - Abscess      R3 - Periodontal Ligament Widening 
C4 - Mobility      R4 - Periapical Radiolucency 
C5 - Premature Exfoliation     R5 - Internal Root Resorption 
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Master Chart 
6 months evaluation 
 
S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 
1 FC 84 N N N N N N N N N 26 FC 74 N N N N N N N N N 
2 FC 75 N N N N N N N N N 27 FC 84 N N N N N N N N N 
3 FC 74 N N N N N N N N N 28 FC 85 N N N N N N N N N 
4 FC 84 N N N N N N N N N 29 FC 74 N N N N N N N N N 
5 FC 85 N N N N N N Y Y N 30 FC 75 N N N N N N N N N 
6 FC 74 N N N N N N N N N 31 FC 74 N N N N N N N N N 
7 FC 84 N N N N N N Y Y N 32 FC 84 N N N N N N N N N 
8 FC 85 N N N N N N N N N 33 FC 85 N N N N N N N N N 
9 FC 74 N N N N N N N N N 34 FC 84 N N N N N N N N N 
10 FC 75 N N N N N N N N N 35 FC 85 N N N N N N N N N 
11 FC 74 N N N N N N N N N 36 FC 84 N N N N N N N N N 
12 FC 74 N N N N N N N Y N 37 FC 75 N N N N N N N N N 
13 FC 85 N N N N N N N N N 38 FC 74 N N N N N N N N N 
14 FC 84 N N N N N N N N N 39 FC 85 N N N N N N N N N 
15 FC 74 N N N N N N N Y N 40 FC 74 N N N N N N N N N 
16 FC 75 N N N N N N N N N 41 FC 84 N N N N N N N N N 
17 FC 74 N N N N N N N N N 42 FC 85 N N N N N N N N N 
18 FC 85 N N N N N N N N N 43 FC 74 N N N N N N N N N 
19 FC 84 N N N N N N N N N 44 FC 84 N N N N N N N N N 
20 FC 74 N N N N N N N N N 45 FC 75 N N N N N N N N N 
21 FC 85 N N N N N N N N N 46 FC 74 N N N N N N N N N 
22 FC 84 N N N N N N N Y N 47 FC 84 N N N N N N N N N 
23 FC 85 N N N N N N N N N 48 FC 75 N N N N N N N N N 
24 FC 75 N N N N N N N N N 49 FC 85 N N N N N N N N N 
25 FC 84 N N N N N N N N N 50 FC 84 N N N N N N N N N 
     
C1 - Pain       R1 - Abnormal Root Resorption 
C2 - Fistula       R2 - Inter Radicular Radiolucency 
C3 - Abscess      R3 - Periodontal Ligament Widening 
C4 - Mobility      R4 - Periapical Radiolucency 
C5 - Premature Exfoliation     R5 - Internal Root Resorption 
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Master Chart 
6 months evaluation 
 
S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 
51 MTA 75 N N N N N N N N N 76 MTA 84 N N N N N N N N N 
52 MTA 84 N N N N N N N N N 77 MTA 75 N N N N N N N N N 
53 MTA 74 N N N N N N N N N 78 MTA 85 N N N N N N N N N 
54 MTA 85 N N N N N N N N N 79 MTA 84 N N N N N N N N N 
55 MTA 74 N N N N N N N N N 80 MTA 75 N N N N N N N N N 
56 MTA 75 N N N N N N N N N 81 MTA 74 N N N N N N N N N 
57 MTA 74 N N N N N N N N N 82 MTA 75 N N N N N N N N N 
58 MTA 84 N N N N N N N N N 83 MTA 74 N N N N N N N N N 
59 MTA 75 N N N N N N N N N 84 MTA 85 N N N N N N N N N 
60 MTA 74 N N N N N N N N N 85 MTA 84 N N N N N N N N N 
61 MTA 74 N N N N N N N N N 86 MTA 75 N N N N N N N N N 
62 MTA 85 N N N N N N N N N 87 MTA 84 N N N N N N N N N 
63 MTA 74 N N N N N N N N N 88 MTA 74 N N N N N N N N N 
64 MTA 75 N N N N N N N N N 89 MTA 84 N N N N N N N N N 
65 MTA 84 N N N N N N N N N 90 MTA 85 N N N N N N N N N 
66 MTA 74 N N N N N N N N N 91 MTA 75 N N N N N N N N N 
67 MTA 75 N N N N N N N N N 92 MTA 84 N N N N N N N N N 
68 MTA 85 N N N N N N N N N 93 MTA 74 N N N N N N N N N 
69 MTA 74 N N N N N N N N N 94 MTA 75 N N N N N N N N N 
70 MTA 75 N N N N N N N N N 95 MTA 74 N N N N N N N N N 
71 MTA 84 N N N N N N N N N 96 MTA 84 N N N N N N N N N 
72 MTA 84 N N N N N N N N N 97 MTA 75 N N N N N N N N N 
73 MTA 75 N N N N N N N N N 98 MTA 84 N N N N N N N N N 
74 MTA 74 N N N N N N N N N 99 MTA 85 N N N N N N N N N 
75 MTA 85 N N N N N N N N N 100 MTA 75 N N N N N N N N N 
 
C1 - Pain       R1 - Abnormal Root Resorption 
C2 - Fistula       R2 - Inter Radicular Radiolucency 
C3 - Abscess      R3 - Periodontal Ligament Widening 
C4 - Mobility      R4 - Periapical Radiolucency 
C5 - Premature Exfoliation     R5 - Internal Root Resorption 
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Master Chart 
9 months evaluation 
 
S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 
1 FC 84 N N N N N N N N N 26 FC 74 N N N N N N N N N 
2 FC 75 N N N N N N N N N 27 FC 84 N N N Y N N Y Y N 
3 FC 74 N N N N N N N N N 28 FC 85 N N N N N N N N N 
4 FC 84 N N N N N N N N N 29 FC 74 N N N N N N N N N 
5 FC 85 N N N N N N Y Y N 30 FC 75 N N N N N N N N N 
6 FC 74 N N N N N N N N N 31 FC 74 N N N N N N N Y N 
7 FC 84 N N N Y N N Y Y N 32 FC 84 N N N N N N N N N 
8 FC 85 N N N N N N N N N 33 FC 85 N N N N N N N N N 
9 FC 74 N N N N N N N N N 34 FC 84 N N N N N N N N N 
10 FC 75 N N N N N N N N N 35 FC 85 N N N N N N N N N 
11 FC 74 N N N N N N N N N 36 FC 84 N N N N N N N N N 
12 FC 74 N N N N N N N Y N 37 FC 75 N N N Y N N Y Y N 
13 FC 85 N N N N N N N N N 38 FC 74 N N N N N N N N N 
14 FC 84 N N N N N N N N N 39 FC 85 N N N N N N N N N 
15 FC 74 N N N N N N N Y N 40 FC 74 N N N N N N N N N 
16 FC 75 N N N N N N N N N 41 FC 84 N N N N N N N N N 
17 FC 74 N N N N N N N N N 42 FC 85 N N N N N N N N N 
18 FC 85 N N N N N N N N N 43 FC 74 N N N N N N N N N 
19 FC 84 N N N N N N N N N 44 FC 84 N N N N N N N N N 
20 FC 74 N N N N N N N N N 45 FC 75 N N N N N N N N N 
21 FC 85 N N N N N N N N N 46 FC 74 N N N N N N N Y N 
22 FC 84 N N N Y N Y Y Y N 47 FC 84 N N N N N N N N N 
23 FC 85 N N N N N N N N N 48 FC 75 N N N N N N N N N 
24 FC 75 N N N N N N N N N 49 FC 85          
25 FC 84 N N N N N N N N N 50 FC 84          
 
C1 - Pain       R1 - Abnormal Root Resorption 
C2 - Fistula       R2 - Inter Radicular Radiolucency 
C3 - Abscess      R3 - Periodontal Ligament Widening 
C4 - Mobility      R4 - Periapical Radiolucency 
C5 - Premature Exfoliation     R5 - Internal Root Resorption 
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Master Chart 
9months evaluation 
 
S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 
51 MTA 75 N N N N N N N N N 76 MTA 84 N N N N N N N N N 
52 MTA 84 N N N N N N N N N 77 MTA 75 N N N N N N N N N 
53 MTA 74 N N N N N N N N N 78 MTA 85 N N N N N N N N N 
54 MTA 85 N N N N N N N N N 79 MTA 84 N N N N N N N N N 
55 MTA 74 N N N N N N N N N 80 MTA 75 N N N N N N N N N 
56 MTA 75 N N N N N N N N N 81 MTA 74 N N N N N N N N N 
57 MTA 74 N N N N N N N N N 82 MTA 75 N N N N N N N N N 
58 MTA 84 N N N N N N N N N 83 MTA 74 N N N N N N N N N 
59 MTA 75 N N N N N N N N N 84 MTA 85 N N N N N N N Y N 
60 MTA 74 N N N N N N N N N 85 MTA 84 N N N N N N N N N 
61 MTA 74 N N N N N N N N N 86 MTA 75 N N N N N N N N N 
62 MTA 85 N N N N N N N N N 87 MTA 84 N N N N N N N N N 
63 MTA 74 N N N N N N N N N 88 MTA 74 N N N N N N N N N 
64 MTA 75 N N N N N N N N N 89 MTA 84 N N N N N N N N N 
65 MTA 84 N N N N N N N N N 90 MTA 85 N N N N N N N N N 
66 MTA 74 N N N N N N N N N 91 MTA 75 N N N N N N N N N 
67 MTA 75 N N N N N N N N N 92 MTA 84 N N N N N N N N N 
68 MTA 85 N N N N N N N Y N 93 MTA 74 N N N N N N N N N 
69 MTA 74 N N N N N N N N N 94 MTA 75 N N N N N N N N N 
70 MTA 75 N N N N N N N N N 95 MTA 74 N N N N N N N N N 
71 MTA 84 N N N N N N N N N 96 MTA 84 N N N N N N N N N 
72 MTA 84 N N N N N N N N N 97 MTA 75 N N N N N N N N N 
73 MTA 75 N N N N N N N N N 98 MTA 84          
74 MTA 74 N N N N N N N N N 99 MTA 85          
75 MTA 85 N N N N N N N N N 100 MTA 75          
 
C1 - Pain       R1 - Abnormal Root Resorption 
C2 - Fistula       R2 - Inter Radicular Radiolucency 
C3 - Abscess      R3 - Periodontal Ligament Widening 
C4 - Mobility      R4 - Periapical Radiolucency 
C5 - Premature Exfoliation     R5 - Internal Root Resorption 
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Master Chart 
12 months evaluation 
 
S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 
1 FC 84 N N N N N N N N N 26 FC 74 N N N N N N N N N 
2 FC 75 N N N N N N N N N 27 FC 84 N N N Y N N Y Y N 
3 FC 74 N N N N N N N N N 28 FC 85 N N N N N N N N N 
4 FC 84 N N N N N N N N N 29 FC 74 N N N N N N N N N 
5 FC 85 N N N N N N Y Y N 30 FC 75 N N N N N N N N N 
6 FC 74 N N N N N N N N N 31 FC 74 N N N N N N N Y N 
7 FC 84 N N N Y N N Y Y N 32 FC 84 N N N N N N N N N 
8 FC 85 N N N N N N N N N 33 FC 85 N N N N N N N N N 
9 FC 74 N N N N N N N N N 34 FC 84 N N N N N N N N N 
10 FC 75 N N N N N N N N N 35 FC 85 N N N N N N N N N 
11 FC 74 N N N N N N N N N 36 FC 84 N N N N N N N N N 
12 FC 74 N N N N N N N Y N 37 FC 75 N N N Y N Y Y Y N 
13 FC 85 N N N N N N N N N 38 FC 74 N N N N N N N N N 
14 FC 84 N N N N N N N N N 39 FC 85 N N N N N N N N N 
15 FC 74 N N N N N N Y Y N 40 FC 74 N N N N N N N N N 
16 FC 75 N N N N N N N N N 41 FC 84 N N N N N N N Y N 
17 FC 74 N N N N N N N N N 42 FC 85 N N N N N N N N N 
18 FC 85 N N N N N N N N N 43 FC 74 N N N N N N N N N 
19 FC 84 N N N N N N N N N 44 FC 84 N N N N N N N N N 
20 FC 74 N N N N N N N N N 45 FC 75 N N N N N N N N N 
21 FC 85 N N N N N N N N N 46 FC 74 N N N N N N Y Y N 
22 FC 84 N N N Y N Y Y Y N 47 FC 84          
23 FC 85 N N N N N N N N N 48 FC 75          
24 FC 75 N N N N N N N N N 49 FC 85          
25 FC 84 N N N N N N N N N 50 FC 84          
         
C1 - Pain       R1 - Abnormal Root Resorption 
C2 - Fistula       R2 - Inter Radicular Radiolucency 
C3 - Abscess      R3 - Periodontal Ligament Widening 
C4 - Mobility      R4 - Periapical Radiolucency 
C5 - Premature Exfoliation     R5 - Internal Root Resorption 
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Master Chart 
12months evaluation 
 
S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 S.No Group Teeth C1 C2 C3 C4 C5 R1 R2 R3 R4 
51 MTA 75 N N N N N N N N N 76 MTA 84 N N N N N N N N N 
52 MTA 84 N N N N N N N N N 77 MTA 75 N N N N N N N N N 
53 MTA 74 N N N N N N N N N 78 MTA 85 N N N N N N N N N 
54 MTA 85 N N N N N N N N N 79 MTA 84 N N N N N N N N N 
55 MTA 74 N N N N N N N N N 80 MTA 75 N N N N N N N N N 
56 MTA 75 N N N N N N N N N 81 MTA 74 N N N N N N N N N 
57 MTA 74 N N N N N N N N N 82 MTA 75 N N N N N N N N N 
58 MTA 84 N N N N N N N N N 83 MTA 74 N N N N N N N N N 
59 MTA 75 N N N N N N N N N 84 MTA 85 N N N N N N N Y N 
60 MTA 74 N N N N N N N N N 85 MTA 84 N N N N N N N N N 
61 MTA 74 N N N N N N N N N 86 MTA 75 N N N N N N N N N 
62 MTA 85 N N N N N N N N N 87 MTA 84 N N N N N N N N N 
63 MTA 74 N N N N N N N N N 88 MTA 74 N N N N N N N N N 
64 MTA 75 N N N N N N N N N 89 MTA 84 N N N N N N N N N 
65 MTA 84 N N N N N N N N N 90 MTA 85 N N N N N N N N N 
66 MTA 74 N N N N N N N N N 91 MTA 75 N N N N N N N N N 
67 MTA 75 N N N N N N N N N 92 MTA 84 N N N N N N N N N 
68 MTA 85 N N N N N N Y Y N 93 MTA 74 N N N N N N N N N 
69 MTA 74 N N N N N N N N N 94 MTA 75 N N N N N N N N N 
70 MTA 75 N N N N N N N N N 95 MTA 74 N N N N N N N N N 
71 MTA 84 N N N N N N N N N 96 MTA 84 N N N N N N N N N 
72 MTA 84 N N N N N N N N N 97 MTA 75 N N N N N N N N N 
73 MTA 75 N N N N N N N N N 98 MTA 84          
74 MTA 74 N N N N N N N N N 99 MTA 85          
75 MTA 85 N N N N N N N N N 100 MTA 75          
 
C1 - Pain       R1 - Abnormal Root Resorption 
C2 - Fistula       R2 - Inter Radicular Radiolucency 
C3 - Abscess      R3 - Periodontal Ligament Widening 
C4 - Mobility      R4 - Periapical Radiolucency 
C5 - Premature Exfoliation     R5 - Internal Root Resorption
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Histology Chart 
 
 
 
 
 
 
 
 
 
 
 
SNo: Characteristics Formocresol 
 
 
MTA Control-Freshly 
Extracted Teeth 
1 Integrity of 
odontoblast 
 
 
   
2 Dentine 
Bridge 
 
 
   
3 Intra Pulpal 
calcifications 
 
 
   
4 Inflammatory 
status 
 
 
 .  
5 Reversal 
/resting line  
 
   
